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Abstract 
Research Purpose:  
To ascertain whether nurses’ skill, self-efficacy and attitudes remain enhanced 8 months 
after a two-day Relapse Prevention (RP) and Medication Concordance (RPMC) training 
programme. 
Relevance:  
Patients relapse in high numbers due to poor concordance with medication regimes. An 
absence of evidence-based nurse training in medication concordance (MC) and RP 
contributes to these relapses, leading to high societal cost in relation to delayed 
discharge; early return to hospital or health centres; delays in return to work and 
increased resistance to drugs. 
Methods:  
A mixed method sequential design with some controls was employed. Participants were 
recruited from a large, mixed provision, NHS provider Trust. Some 21 nurses at Band 
5/6 were recruited and divided into two groups to facilitate training. Each group was 
given two consecutive days of RPMC training supported by a comprehensive manual. 
The group was then assessed for changes in skill capability and self-efficacy at baseline 
(Point 1), 1 week post-RPMC training (Point 2) and at 8 months follow up (Point 3). 
Attitude changes were only measured at Point 1 and Point 3. Additionally, five 
participants were interviewed 10 weeks post-RPMC to gain insight into their actual MC 
and RP practice. Full ethics committee approval was obtained for this study. 
Results:  
A two-tailed Wilcoxon Rank test to measure within-group changes showed significant 
change in Skills Capability scores between Points 1 and 2 (p=0.002), but no significant 
difference between Points 2 and 3 (p=0.444). Self–efficacy scores showed equally 
significant changes between Points 1 and 2 (p=0.041); Point 2 (p=0.002) and Point 3 
(p=0.05) Significant increase in self-efficacy was seen between Points 1 and Point 3 
(p=0.026) as well as differences in attitude scores between Point 1 and Point 3 
(p=0.007).  
ix 
The qualitative results showed the participants gained new insight and also 
improvement in their confidence, skills capability and attitude towards developing 
better understanding and partnership working to provide better choices for patients to 
take their medication.  
Conclusion:  
The RPMC two-day course improved skills capability, self-efficacy and attitudes of 
mental health nurses (MHNs) at an 8 months follow up. 
Implications:  
A Randomised Control Trial should now be conducted to assess whether these results 
are replicated and sustained among nurses and to improve MC capability in patients in 
Mental Health Services. 
Key words:  
Medication, concordance, adherence, compliance, skills, beliefs, attitudes and relapse 
prevention.  
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 Chapter 1 Introduction 
This dissertation is in five chapters. In the introductory chapter, a brief rationale will be 
given, including the extent of non-adherence of medication in mental health, and the 
political and guidelines context of this issue. Also presented is the role of the psychiatric 
nurse in medication concordance (MC), and the case for relapse prevention and 
medication concordance (RPMC), along with the aims and objectives of the study. 
The second chapter describes the search strategy and provides a literature review 
examining and critiquing papers relevant to this study. 
The third chapter includes the research methodology and methods, the hypothesis and 
null hypothesis and the inclusion and exclusion criteria of the study sample. This 
chapter consists of samples and sampling methodology, along with the research design, 
data collection and any ethical considerations. Also presented are the study measures 
used to provide quantitative and qualitative data and the statistical tests used, including 
methods to analyse the data collection. 
The fourth chapter is divided into four sections. In Section 1, the quantitative results are 
presented. In Section 2, the rationale and approach to the thematic analysis are 
discussed. In Section 3, the qualitative findings from the thematic analysis of the 
emerging themes from the focus group are discussed. Finally, in Section 4, the 
quantitative integration of the qualitative findings is examined.  
Chapter 5 consists of discussions on the overall findings of the study. Also presented are 
the methodological limitations and procedural difficulties as well as the implications this 
study could have on MH nursing education/training practice. 
1.1 Extent of Non-Adherence to Medication in Mental Health 
Non-adherence to medication in mental health (MH) is a problem that is reflected 
nationally and internationally (Gray et al., 2010), with an average incidence of 50 per 
cent (Gray et al., 2002, 2010; Gilmer et al., 2004) over the past three decades. This has 
resulted in poor outcomes impeding recovery, increasing relapse rates, higher rates of 
suicide (Higashi et al., 2013), greater hospital bed usage (Haywood et al., 1995; Weiden 
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 et al., 2004; Valenstein et al., 2006) and high societal costs (Foster and Jumnoodoo, 
2008) if treatment is not addressed effectively and promptly (Mitchell and Selmes, 
2007). To date, interventions used to address the issue of MC have produced mixed 
results not sustainable over time (see Chapter 2, Summary). As a result, a new approach 
is needed if psychiatric nurses are to make a sustainable difference in medication 
concordance (MC). 
1.2 Political Context and Guidelines of Relapse Prevention and Medication 
Concordance (RPMC) 
RPMC fits well with several DH initiatives such as the Care programme approach (DH, 
1990), NICE guidance on medication adherence (NICE 2009), Effective Healthcare 
Coordination in MH services (DH, 1999), the Good Practice Guide for CMHT (DH, 2002) 
and those at the Social Care Institute for Excellence (SCIE, 2007), and key factors 
affecting adherence, identified in the WHO report (WHO 2003). All recommend 
psychological interventions to improve adherence to medication. To date, this position 
has not changed, and in the current literature it is recognised that there is no definitive 
use of a single model of MC that NICE (2009) guidelines can recommend. The recent 
study by York Health Economics consortium and the School of Pharmacy, University of 
London (2010), supported by Kongkaew et al. (2013) and Boswell et al. (2013), suggests 
that there is a clear relationship between medication adherence, a reduction in hospital 
admissions and improved outcomes in terms of costs and wellbeing among those with 
chronic conditions, including serious and enduring mental illness. However, new 
initiatives to improve medication adherence remain a challenge due to major 
compounding issues such as the nature of the illness, how patients view their 
medication, and the information they receive, especially about the negative 
consequences of taking medication and clear strategy to help overcome non-adherence 
(Greenburg, 2013).  
It can be seen that testing the RPMC programme is an adjunct to existing interventions 
on medication adherence, offering alternative choices to mental health nurses (MHNs) 
in practice. 
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 1.3 Role of Psychiatric Nurses in MC 
Whilst it is often believed that taking medication is solely the role and responsibility of 
service users (SUs), it is also recognised that nurses play a vital part in managing, 
supporting and encouraging medication adherence (Gray et al., 2002; Coombs et al., 
2003). This suggests that the overall responsibility for the extent of adherence is a 
nursing role (Byrne et al., 2008). Therefore, nurses’ involvement in RPMC is equally 
important. 
1.4 Case for Relapse Prevention and Medication Concordance (RPMC) 
The term ‘relapse prevention’ was originally coined by Marlatt and Gordon (1985: 3) in 
the treatment of addictive behaviours. They defined relapse prevention as a ‘self-
management program designed to enhance the maintenance stage of the habit-change 
process’. 
1.5 Theoretical Perspective of RP 
RP is based on cognitive behavioural therapy (CBT) (Beck et al., 1977) and social learning 
theory (Bandura, 1979). It is purposeful to use this cognitive behavioural tool, that 
Jumnoodoo et al. (2002) have coined ‘the whole system approach’, to model patients’ 
and nurses’ experience and enhance their training and practice. All concepts used in the 
RPMC programme are described in Appendix 1. 
1.6 RPMC Programme 
As mentioned earlier, the proposed 10-session RPMC programme, in comparison to 
other studies, is highly structured (Appendix 2), simple to understand and simple to put 
into practice. As an accredited module by Middlesex University to train MHNs, SUs, 
carers and other MH professionals to improve MC, it has been in practice for the past 
seven years. The programme has undergone several evaluations with commendable 
outcomes.  
Furthermore, the RP project in its various applications in MH services has won four 
national awards and most recently, in 2014, was endorsed by NHS England, which 
recommended its diffusion throughout the UK. Despite commendable outcomes, RPMC 
has not been formally tested in MH services on nurses’ skill capability, self-efficacy and 
attitudes towards MC.  
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 1.7 Purpose of the Study 
The purpose of the study is to find and measure the changes in skills capability, self-
efficacy and attitudes in MHNs following a two-day RPMC training programme 
supported by a comprehensive manual.  
1.8 Aims 
To investigate the effects of a two-day RPMC teaching programme, designed by the 
current applicant, for community psychiatric nurses (CPNs) at Band 5 and 6. 
1.9 Objectives 
The objectives of the study are to measure the immediate and medium-term changes in 
standardised scale scores relating to: 
1.  Skills capability 
2.  Self-efficacy, and 
3.  Attitudes of psychiatric nurses (Band 5 and 6) towards MC. 
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 Chapter 2 Literature Review 
2.1 Search Strategies 
The PICO acronym (Population, Intervention, Comparison, if any, and Outcome) 
framework was used to break down the research question into its different sections to 
obtain the fullest possible picture of terminological variations linked to the search 
components. 
First, the best-fit database for the research question was identified. As nurses form the 
target audience, the CINAHL (Cumulative Index of Nursing and Allied Health Literature) 
was searched, followed by the BNI (British Nursing Index). However, as other clinical 
databases might contain articles of interest to nurses, as well as references to the topic 
under observation (medication adherence) – albeit from different perspectives – it was 
decided also to search PsycINFO, EMBASE and MEDLINE. The NICE Evidence interface 
was used for all searches, that is, the Healthcare Databases Advanced Search (HDAS). 
Different search strategies had to be devised in order to maximise retrieval in each 
database, resorting to a combination of available subject headings and free text 
approaches.  
The geographical context limit (UK only) was initially applied but then removed due to 
practical (a dearth of UK-based findings) and principled reasons (learning from good 
practice elsewhere). The search covered 1998–2014, and was limited to articles in the 
English language. 
The search yielded 14 studies originating in the UK, USA, Australia, Hong Kong, 
Amsterdam (Netherlands), Leipzig (Germany) and Verona (Italy). Ten of the 14 articles 
were selected, one being qualitative and the remaining quantitative.  
2.1.1 Search strategy and history 
First I conducted the search looking at the titles and abstracts (free text searching), 
using the truncation sign (*) to retrieve all derivatives of relevant word stems. Next I 
embarked on a search for all available subject headings by enabling the ‘map to 
Thesaurus’ feature. 
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 Each search component was retrieved in full, separately (free text and subject headings, 
with results united via an OR operator). 
Finally, all three search sections were merged by means of the AND Boolean operator, 
thus identifying the semantic intersection between medication 
concordance/training/mental health nurses. 
2.1.2 CINAHL search history 
1. CINAHL; Patient compliance/ or medication compliance/; 24,113 results 
2. CINAHL; "medication complian*".tx OR "treatment complian*".tx OR medication 
adher*".tx OR "treatment adher*".tx OR "medication concord*".tx OR 
"treatment concord*".tx OR "patient compliance".tx OR non-compliance.ti OR 
non- adherence.ti OR non-concordance.ti; 34125 results 
3. CINAHL; 1 OR 2; 34125 results 
4. CINAHL; "training programme*".tx; 9981 results 
5. CINAHL; education.mw; 317679 results 
6. CINAHL; training.mw; 22951 results 
7. CINAHL; 4 OR 5 OR 6; 338724 results 
8. CINAHL; Psychiatric nursing/ or community mental health nursing/; 14860 
results 
9. CINAHL; exp Antipsychotic agents; 8992 results 
10. CINAHL; 8 OR 9; 23670 results 
11. CINAHL: 6 AND 10 AND 13; 188 results 
12. CINAHL: 11 [Limit to: publication year 1998–2015 and (language English)]; 160 
results. 
Search Date: 14/04/2015 
2.2 Effectiveness of Psychosocial Intervention 
In response to this serious clinical need, several research studies have been conducted 
to evaluate the effectiveness of psychosocial interventions designed to improve 
adherence to psychotropic medication. The application of psycho/behavioural 
education, cognitive behavioural therapy (CBT) and family intervention studies has 
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 benefitted patients, however the duration of these studies’ effectiveness was short and 
the benefits had limitations (Gray et al., 2002). 
2.3 Terms Used in RPMC 
The words compliance, adherence and concordance are used interchangeably in the 
context of prescribed medicine-taking behaviour (Royal Pharmaceutical Society of Great 
Britain, 1997). In MC engagement, the clinicians and the patients make shared decisions 
(Deegan and Drake, 2006), and lean more towards patient values, views and options 
including sharing information and uncertainties, which gives patients the autonomy to 
run the risk of relapse or to welcome the benefits of taking medication (National 
Institute for Health and Clinical Excellence (NICE), 2009a). (Refer to Appendix 3 for more 
information regarding this section.) 
The term ‘concordance’ indicates a relationship between the two experts, the service 
user and the professional, whereby there is a sharing of information to understand the 
service users' values, beliefs, attitudes and skills and subsequently to discuss and agree 
a care plan towards his or her prescribed medication.  
Coombs et al. (2003), in an Australian research paper, articulate that shared decisions 
may not be effective. This is because 84 per cent of nurses who participated in their 
study did not have any prior education or training in medication adherence strategies. 
Although it is a legitimate role of nurses to encourage MC, to date psychiatric nurses 
remain poorly trained (Feros et al., 2010; Cormack, 1996). 
2.4 Limitations of NICE Guidelines 
However, NICE guidelines (2009b) advocate that adherence therapy should not be used 
routinely for the treatment of psychosis. This recommendation has serious implications 
in practice, as choices of treatment are imposed on patients and clinicians, 
consequently affecting medication compliance and leading to an exacerbation of their 
mental condition and an increase in relapse rates. It may be argued that if certain 
components of adherence therapy are integrated with other interventions, such as RP, 
they may produce better outcomes that may be more sustainable. 
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 2.5 Rationale for Psychiatric Nurses’ Training in MC 
Byrne et al. (2005) acknowledge that attitudes, skills, beliefs and confidence apply 
equally to patients and nurses in changing their approach to improve MC. Therefore, 
specific nurse training programmes and further research into educational needs of 
nurses are needed to improve MC. This sense of direction is endorsed by NICE (2009c: 
20), which advocates the development of an ‘effective, equitable interventions to 
support adherence to appropriate prescriptions’, and to have ‘informed choice and 
shared decision making through cost-effective ways of communication’. 
Furthermore, the need to train MHNs specifically in medication management was 
highlighted by Julia Jones (2003) of the Royal College of Nursing; it is common practice 
in most areas of healthcare such as osteoarthritis (NICE, 2008) and Type 2 diabetes 
(NICE, 2009d). New developments in this area are also supported by the Guideline 
Development Group (GDG) in partnership with the Royal College of Psychiatrists and 
NICE (2014). 
To date, from the literature search, interventions used in the training of MHNs were 
found to be mainly focused on Compliance Therapy (CT) or related interventions such as 
Medication Management Training (MMT) therapy and Medication Alliance Therapy 
(MAT).  
2.6 Inclusion and Exclusion of Studies 
Given the paucity of literature that directly evaluates the relationship between MHNs 
using ‘best practice’ adherence therapies, the present study will focus exclusively on 10 
(of 14) studies with a direct or indirect bearing on the training of MHNs to improve MC. 
Other studies such as by Parashos et al. (1999), Kavanagh et al. (2003), Merinder et al. 
(1999) and Peveler et al. (1999) were interventions aimed directly at educating patients 
to improve MC, and were studied but excluded from the main dissertation.  
2.7 Compliance Therapy 
To date, from the search, interventions used in the training of MHNs have mainly 
focused on Compliance Therapy (CT) or related interventions such as Medication 
Management Training (MAT) therapy and Medication Alliance Therapy (MAT). 
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 CT has gained wide interest through the work of Kemp et al. (1996, 1997, 1998). CT 
comes mainly from two sources: CBT and Motivational Interviewing Techniques (MIT) 
(Miller and Rollnick, 1991). 
2.8 Study Outcomes of CT 
Kemp et al. (1998) tested CT theory by conducting a randomised control trial with 74 
patients with psychotic illness, resulting in improved insight into patients’ illness, better 
attitudes towards treatment, reduction in hospital admissions and increased levels of 
treatment compliance/concordance. However, two other research studies using CT 
have failed to replicate their findings (O’Donnell et al., 2003; Byerly et al., 2005). 
Despite these failings, other researchers have used modified versions of CT in nurses’ 
training to improve adherence of medication. 
2.9 Medication Management Training (MMT) and Community MHNs 
Gray et al. (2003) conducted a quantitative research with a convenience sample size of 
52 MHNs with a minimum of 12 months’ experience, selected from two large MH care 
providers in London. The aim of the study was to investigate whether a 10-day MMT-
based programme was effective in improving the clinical skills of Community MHNs. 
MMT is based on pharmacology, discussion on the link between practical strategies, 
stopping medication and staying well.  
Data was collected at pre-, immediately post-training and at 26 weeks follow up, using 
knowledge and medication management semi-structured questionnaires. Results of this 
study were positive, indicating a significant improvement in skills and in factual and 
functional knowledge.  
The results may have been influenced by the method of data collection, involving role 
play before and after training to reinforce knowledge and skill competencies. Similarly, 
anxiety about being videotaped during role play may have diminished post-training, 
thus yielding a positive result. The study was uncontrolled with no comparison group 
and its durability is uncertain in the long term. The training contents were not detailed. 
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 Following their original investigation, Gray et al. (2004) conducted another quantitative 
study, designed as a cluster randomised control trial with a sample size of 60 CMHNs 
randomly selected from two MH care providers in London.  
The CMHNs were each required to pick two patients from their caseload for the trial. 
The aim of the study was to investigate whether MMT is better than ‘treatment as 
usual’ (TAU) in improving clinical outcomes for patients with schizophrenia.  
The CMHNs received 80 hours of MMT delivered over 10 weeks. Data was collected at 
baseline and 26 weeks after training using the positive and negative syndrome scale 
(PANSS), which had a reputable construct validity (Kay et al., 1989, cited by Gray et al., 
2004). The results were that nurses who had received MMT produced a considerably 
greater reduction in clients’ general psychopathology than TAU at 26 weeks post-
training.  
The positive results may have been influenced by the fact that nurses had the freedom 
to choose patients with whom they had a good relationship and who potentially would 
do well in this study. Therefore, the results of this study cannot be generalised. 
2.9.1 The Quatro study  
Gray et al. (2006) conducted an experiment using adherence therapy with people with 
schizophrenia in a European multi-centre randomised controlled trial in Amsterdam (the 
Netherlands), Leipzig (Germany), London (England) and Verona (Italy). The main aim of 
the study was to compare the effectiveness of medication adherence therapy (MAT) 
and a health education control intervention on the quality of life for patients with 
schizophrenia receiving treatment in psychiatric services. The interventions were 
delivered by trained and clinically experienced therapists. Throughout the study, the 
data collection at the baseline and follow-up stages was masked from the researcher 
allocating the participants. In each group, participants were given up to eight weekly 
sessions of MAT or health education programme based details in manuals. There were 
204 participants in the adherence therapy group and 205 in the health education group. 
At the one year follow up, 178 participants in the adherence therapy group and 194 in 
the education group had completed the study. 
10 
 The results showed no difference in the quality of life at baseline and after the one year 
follow up, and also no significant difference between MAT and health education at the 
same time points. Equally, there was no significant difference between the 
experimental and control groups at baseline and at follow up in terms of 
psychopathology. 
It is plausible that the number of therapy sessions delivered over five months was 
insufficient and, with no booster sessions, the participants may not have had enough 
time to discuss their individual issues relating to adherence to medication and therefore 
did not improve. The participants, despite the inclusion criteria of evidence of disability 
and the ability to self-report treatment of adherence, may not have benefitted from the 
interventions, as these did not form part of their regular treatment. 
2.9.2 Follow up Quatro study 
This study was further explored with the available quantitative data to examine the 
relationship between non-adherence and health and social care costs, and societal costs 
(King et al., 2014). The results of non-adherence on costs was mixed; that is, they were 
both positively and negatively associated with costs. The tendency leaned towards 
lower inpatient costs and higher odds of using community-based services among those 
who self-reported adherence to medication, compared to those who did not. Therefore 
the results cannot be generalised and suggest that other forms of psychosocial 
interventions need to be explored and with qualitative data analysis. 
2.10 Medication Alliance Therapy (MAT) Training and Mental Health 
(MH) Workers 
Another study conducted by Byrne et al. (2005) tested the impact of a three-day MAT 
on attitudes and work satisfaction of 23 MH workers, mostly community-based 
psychiatric nurses, in Australia. MAT is based on CT, focusing on identifying the causes 
of non-compliance of medication, engagement, questioning strategies, individual 
assessment and illness timelines and interventions. 
The training was delivered in two groups with pre- and post-training measures, 
including a videotaped role play. The overall results were positive, with significant 
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 changes in post-training attitudes, skill capability, work satisfaction, optimism, empathy 
and self-esteem.  
There was no comparison group to compare the positive findings. The results should 
have been more persuasive if a qualitative approach was used to find out whether 
emerging themes complemented or rejected the findings. The study measures were 
carried out only at pre- and immediately after the training, with no follow-up plan; 
therefore, durability in the long term remains unknown.  
2.11 MAT Training for Mental Health Staff using the Train-the-Trainer 
Model 
The same lead author in the Byrne et al. (2010) study attempted to replicate the 
findings of the previous study in four inpatient settings in the US, using the train-the-
trainer model with the opportunity of training the trainers. Some 113 MH staff were 
recruited, of whom 52 per cent were nurses and the remainder technicians, social 
workers, psychiatrists, psychologists and occupational therapists. Some 67 MH staff 
were recruited from two wards in the expert-trained group and the other 46 MH staff 
were allocated from the remaining two wards, representing the novice-trained group. 
The novice-trained group attended training six months after the expert group, and were 
trained by selected trainees from the expert group.  
The measures used at pre- and immediately post-training showed significant 
improvement across both groups for knowledge and attitude, with modest 
improvement in overall skills in both groups, albeit more in the expert group. Attitudes 
improved significantly in both groups, but these outcomes were not found in the overall 
results. It is plausible that the poor results in attitude were not specifically targeted in 
the MAT programme.  
2.12 MAT Training of Nurses and Patients 
The participants did not show the expected results in identifying reasons for non-
concordance, which may have been due to poor delivery of the training. Therefore, the 
authors of this study need to identify the weaknesses of the programme before 
advocating dissemination. There was also no measure of durability of improvements 
and comparison group. 
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 Finally, Byrne and Deane (2011) tested the effects of a three-day MAT on clinicians and 
its impact on patients’ adherence to medication in Australia. Fifty-five clinicians 
volunteered to participate including 39 nurses; the remaining staff members were made 
up of other healthcare professionals. Only 36 staff completed the study, with 38 
patients providing a full data set at 12 months.  
There were significant improvements in clinical measures immediately post-training in 
knowledge, however variables associated with taking medication showed a 
deterioration in scores of skill, optimism and work satisfaction at six and 12 months. 
There was also an improvement in the therapist/patient relationship for goal-setting 
and agreed task scores between baseline and the six months follow up, and no change 
thereafter.  
There were limitations to this study. The measures used by the clinicians differed from 
those of the patient participants and so it was difficult to compare and interpret the 
data. There was no comparison group to compare the findings and hence the results 
were inconclusive. The participants, clinicians and patients were all volunteers, which 
may have influenced the positive outcomes.  
Bressington, Mui and Wells (2013) conducted a qualitative study to understand how 
these changes impact upon clinical effectiveness over time to maximise the potential of 
treatment with medication, and also on the insight gained by Community Mental Health 
Practitioners (CMHPs).  
Interventions: A five-day course of MMT based on the manualised medication 
adherence approaches and interventions adopted by Gray et al. (2006) and three-day 
clinical practice in Hong Kong. 
Sample: 26 CMHPs completed the training programme 
Methodology and methods: Concept mapping was used in this study. Data was 
collected from 10 invited participants to attend a semi-structured interview after nine 
months about their experience of using MMT techniques and to discuss their 
perceptions of the process of learning. Inductive content analysis was adopted to 
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 analyse and to report themes and patterns within the qualitative interview data (Braun 
and Clarke, 2006). 
Results: Four themes emerged: 1. barriers to implementation; 2. pharmacology 
knowledge increases confidence; 3. changes in attitudes approaches towards non-
adherence, and; 4. pragmatic uses of manualised interventions. 
This study used convenience sampling and concept mapping, a relatively new approach 
to guide the qualitative interviews. This may suggest that the study is exploratory and 
therefore its limitations require further investigation. 
2.13 Key Methodological Issues 
From the above studies, six main conclusive themes emerged: 
Theme 1. Studies using interventions relating to the training of MHNs were conducted 
in different countries: two in London (Gray et al., 2003, 2004); two in Australia (Byrne et 
al., 2005, 2011); and one each in the US (Byrne et al., 2010) and Hong Kong (Bressington 
et al., 2013). The Quatro study was conducted in the four European centres of 
Amsterdam (the Netherlands), Leipzig (Germany), London (England) and Verona (Italy). 
Different cultures, behaviour and attitudes towards MC might have created different 
training outcomes if all were conducted in England. 
Theme 2. The training was conducted by a variety of expert healthcare professionals. 
This suggests that the mode of training delivery might have been different, given that 
the programmes were neither structured nor supported by a comprehensive manual. 
Theme 3. Different study measures were used, some without any established 
psychometric properties; this renders the results of the above studies suspect. These 
studies were based only on quantitative design and should have benefitted from the 
integration of qualitative data, which would have provided an alternative interpretation 
of the data that would have shaped the results with more rigour. Conversely, 
Bressington et al.’s 2013 study used only a qualitative methodology and methods, and 
may have benefitted from also using a quantitative design. 
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 Theme 4. The cohort of some of the studies included various mental health 
professionals (Byrne et al., 2010), meaning that the outcomes might have been different 
if nurses were used exclusively, due to how they are trained and their experience 
gained through practice. 
Theme 5. All the studies were of short duration and the study measures were recorded 
at different time points and, in that context, the outcomes cannot be generalised. 
Theme 6. The structure and content of the courses were not described or tested before 
the studies, apart from those by Gray et al. (2006) and Bressington et al. (2013), 
therefore an assessment of their overall effectiveness cannot be conclusive. 
2.14 Summary 
From the above emerging themes, it can be seen that a new nursing MC education 
programme with a clear evidence-based structure and content is needed to teach 
nurses to improve their knowledge, competency and attitude towards MC. To date, no 
studies have been conducted using the RP model in MC, although Byrne et al. (2004) 
recommend that RP planning be integrated into the core concepts of the MAT.  
The author of this study has over 15 years’ experience using the fidelity of the RP model 
and has conducted two published studies in MH settings (Jumnoodoo et al., 2001; 
Foster and Jumnoodoo, 2008). These used a structured and RP programme, supported 
by a comprehensive manual, which has been recently revised and is used in clinical 
practice (Jumnoodoo and Coyne, 2011). These studies have been significant in patient 
care and its application in practice. In the Jumnoodoo et al. (2001) study the patients 
showed an increase in motivation, insight and control over their illness and gained 
important skills, most notably assertiveness at the six months follow up. Other 
outcomes included a reduction in hospital admissions and duration of stay in hospital as 
a result of improving compliance with medication. The Foster and Jumnoodoo (2008) 
study showed no differences in terms of relapse outcomes in the experimental or 
control groups, apart from knowledge between baseline and 52 weeks improving in the 
experimental group. Most of the changes were observed during the first 12 weeks. In 
both studies, the convenience sample used was small and the duration of the study was 
short.  
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 Despite tentative claims that RP had an effect on improving adherence to medication, 
this theory needs further investigation into whether knowledge, skill capability, self-
efficacy and attitudes of nurses can improve MC after following an RPMC course, 
providing nurses with additional options to current interventions (Feros et al., 2010) to 
improve MC in psychiatric services. 
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 Chapter 3 Methodology and Methods 
3.1 Steering Groups 
Two steering groups were set up to address the central issue of methodology and 
methods in the theory and practice in the study (Wastell, 2008). Their aims were to 
receive expert advice on the development, direction and implementation of the design 
of this research without influencing its fundamental scope and objectives. In that way 
the steering groups provided a logical approach to the structure and integrative 
processes of this study (Coughland and Coghlan, 2002). 
The recommendations were to use a mixed methods research approach and design that 
included the quantitative and qualitative techniques to be used in sequence (Cameron, 
2009) to provide logical structured and integrative processes (Driscoll et al., 2007). The 
quantitative data were collected prior to the qualitative data and at the eight months 
follow up. The integration of the qualitative and the quantitative data took place during 
the interpretation phase of this study, the purpose being to use the qualitative results 
to explain the quantitative findings (O’Cathain et al., 2010). It is recognised that, whilst 
the results of both methods may differ, the primary purpose is for them to support each 
other (Walsham, 2006). 
3.1.1 Quantitative Steering Group  
Advice and guidance were initially sought from the principal academic supervisor, 
followed up with two experts in the field of RP and research respectively. The aim was 
to have an improved designed and theorised RPMC intervention and the findings are 
measured by established and reliable instruments (Hawe et al., 2004). However, since 
evaluation of interventions can be complex, discussions and agreement from the 
steering group to confirm the feasibility and potential of the design of this study were 
established (Bradley et al., 2007; Pelham, 2010). Thereafter, the research approach was 
presented to a group of postgraduates at Middlesex University for their views and for 
any amendments that they felt should be made. Notes and comments from the group 
were noted. Interestingly, most of the comments were on the design of the structured 
programme, which was explained to them in brief. Another recommendation was to 
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 have two separate flow charts to illustrate clearly the quantitative and the qualitative 
approaches of this study (Figures 1 and 2 on p. 20 and p. 21). 
3.1.2 Qualitative Steering Group 
A small advisory steering group was set up. The aim was to search for qualitative 
strategies for ensuring trustworthiness in this study (Shenton, 2004; Rowlston, 2010). 
Prior to the focus group, the themes of the questionnaire were shown to nurses and 
subsequently to selected service users/carers who were au fait with RP. The purpose 
was to bring together personal experiences that would complement the analytical and 
scientific perspective and enhance the study design (Hewlett et al., 2006). Following 
feedback from these two forums, the themes were amended and finalised.  
3.2 Purpose of the Study  
The purpose of the study was to measure the changes in skills capability, self-efficacy 
and attitudes in MHNs following a two-day RPMC training programme supported by a 
comprehensive manual.  
3.3 Research Approach and Design 
A combination of qualitative and quantitative techniques was used. The 
recommendations were to use a mixed methods research approach and design that 
included the quantitative and qualitative techniques to be used in sequence (Cameron, 
2009) to provide logical structured and integrative processes (Driscoll et al., 2007). 
Contrary to traditional methodological ‘camps’, there is a view that both qualitative and 
quantitative methods may be used in a research study to good effect (e.g. Howe, 1988; 
Polit et al., 2001) to yield a more complete analysis by being complementary to each 
other (Creswell et al., 2004). In this context, mixed methods should follow the research 
question in providing the best opportunity to obtain useful, needs-based answers 
(Johnson and Onwuegbuzie, 2004; Tashakkori and Creswell, 2008). In this study, a two-
tailed approach was adopted to ensure the significance of the findings either support 
the hypothesis (Checkland and Howell, 1998; Denis, 2013) of predictions or reject the 
null hypothesis (Frick, 1996; Stang and Poole, 2013; Piedmont, 2014). 
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 3.4 Hypothesis 
The hypothesis of the study is as follows: 
• There is change in skills capability, 
 Between   Baseline (Point 1), Point 2 and at 8 months follow up (Point 3) 
 
• There is change in self-efficacy and,  
 Between   Baseline (Point 1), Point 2 and at 8 months follow up (Point 3) 
 
• There is change in attitude scores 
 Between   Baseline (Point 1) and at 8 months follow up (Point 3) 
3.5 Null Hypothesis  
The null hypothesis of the study is as follows: 
• There is no change in skills capability, 
 Between   Baseline (Point 1), Point 2 and at 8 months follow up (Point 3) 
 
• There is no change in self-efficacy and,  
 Between   Baseline (Point 1), Point 2 and at 8 months follow up (Point 3) 
 
• There is no change in attitude scores 
 Between   Baseline (Point 1) and at 8 months follow up (Point 3). 
3.6 Sequential Explanatory Strategy 
A sequential explanatory strategy to explain and interpret the findings of the primary 
quantitative study was used in this study (Ivankova et al., 2006):  
   RPMC training       Quan (Point 1 and Point 2)           Qual (10 weeks)        Quan (Point 3) 
Key 
Point 1 – Baseline 
Point 2 – Immediately following group  
Point 3 – 8 months after delivery of group sessions. 
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 3.7 Setting, Sample and Sampling Methods 
This study took place in a large community Mental Health Service in a deprived inner-
city area with high demand for inpatient beds. 
A combination of convenience and random sampling methods was used. Randomisation 
was used to create equivalent and representative groups (Gay, 1996). Different services 
were included to recruit participants who were essentially the same, in that they 
matched the variables of the inclusion criteria, thus the study was not at the mercy of 
any sampling bias (Kunz and Oxman, 1998). 
3.8 Sample Recruitment Process  
The initial intention was to recruit 15–20 qualified community or ward-based nurses 
(Bands 5/6) who had not received training in RPMC. All these nurses were on the Trust 
database (72 Band 5 and 60 Band 6). This formed a sampling frame (n=132) and names 
were placed in an urn. Initially 30 were selected by an independent person. Each of 
those selected was then invited by letter (Appendix4) to participate in the programme 
and 25 individuals were recruited in this way. They were then given a consent form to 
complete (Appendix 5) so that they could make an informed decision to participate in 
this study (Cahana and Hurst, 2008) after having read the Participation Information 
Sheet (PIS) (Appendix 6). In the final cohort, the number of participants was reduced to 
21. Two left the Trust soon after the RPMC course; one participant did not respond to 
any questionnaires and another went on maternity leave and subsequently left. 
Selection bias was avoided by not allowing self-selection by individual nurses, thus 
giving them an equal chance of being selected. 
The inclusion and exclusion criteria as identified below were restricted, so as to produce 
stronger results by limiting the sampling frame to those who would potentially benefit 
the most from this study (Richter et al., 2011). 
3.9 Inclusion Criteria  
Inclusion criteria were that participants were Band 5 and 6 and Registered Mental 
Health Nurses who had not previously undergone accredited academic training in any of 
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 the following: post-registration training in motivational interviewing, CBT, RP, MC or 
Social Learning Theory. 
3.10 Exclusion Criteria 
Exclusion criteria were as follows: 
• Non-qualified nurses  
• Qualified nurses employed from a bank or agency, not working in a full-time 
capacity 
• Nurses who had previously undergone accredited academic training in any of the 
following: post-registration training in motivational interviewing, CBT, RP, MC 
and/or Social Learning Theory. 
3.11 Ethical Issues 
3.11.1 Research and Development Compliance  
The project complied with IRAS (Integrated Research Application System) and local R & 
D (Research and Development) procedures of the North Central London Research 
Consortium (Appendix 7). This is in line with the well-established Research Ethics 
Committee (REC) system that operates within the National Health Service (Department 
of Health, 2005; National Patient Safety Agency (Department of Health, 2007). Together 
they set the standards of improving research quality, promoting good practice and 
above all ensuring the safety of the research participants at all stages of the study. 
The local R & D reviewer requested one minor amendment relating to the scale, in 
which 1= Negative and 5= Mostly Positive to Change. Change was implemented to the 
Likert scale with 1= Strongly Disagree to 5= Strongly Agree. As a result, the wording of 
the questions had to be modified somewhat to accommodate this change. 
Notwithstanding, three main ethical issues in the study were envisaged.  
3.11.2 Independence of Researcher and Research Assistant  
The applicant (RJ) delivered the programme and took no further part in data collection. 
All quantitative data collection was facilitated by an independent researcher employed 
for the study and RJ left the room when any data was collected. The purpose was to 
ensure the integrity and veracity of the collected data without being influenced by the 
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 principal researcher, RJ (Deangelis and Fontanarosa, 2010). Furthermore, RJ took no 
part in the delivery of the focus groups, and a similar process was undertaken to collect 
the qualitative data. 
3.11.3 Data Protection  
The participants were informed that they would be given a code known only to the 
research assistant who would enter the data onto a computer. This was so the research 
assistant could ensure follow-up data related to the correct individual. Thereafter, all 
data was recorded, stored and analysed according to the requirements of the Data 
Protection Act, 1998. Specifically, all computerised data would be password protected 
and any transcription tapes stored securely in a locked drawer. Finally each participant 
was informed that the focus group data would be reported in such a way that 
anonymity could be preserved.  
3.11.4 Confidentiality 
We followed the notion that anonymity should be the default position, and this was 
observed throughout the study (Grinyer, 2002). Grinyer advocates a guiding principle 
that participants need to be in control of the disclosure of their identity and their 
contribution. Other information that can help to identify people, for example job title, 
age, gender, length of service, membership of clubs and strongly expressed opinions, 
was kept to a minimum. The belief is that the fewer pieces of information are presented 
together, the more difficult it is to identify someone.  
3.12 Data Collection Methods 
Data were collected from participants at Point 1, 2 and 3. Those from the RPMC Skills 
Capability Questionnaire, the Self-efficacy (SE) Questionnaire and the Leeds Attitude 
towards Concordance Scale (LATCon) were analysed at different times. The first two 
were analysed at Point 1, Point 2 and Point 3. However, the LATCon questionnaire was 
only administered at Points 1 and 3. These intervals were chosen to detect and analyse 
meaningful effects of RPMC on the dependent variables (Gill et al., 2008). The 
qualitative data collection at 10 weeks post-RPMC was carried out to keep it apart from 
the administration of the qualitative surveys, which would risk the participants being 
influenced by their answers (Li et al., 2011) (refer to Figures 1 and 2 below).   
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 Figure 1: Quantitative Flow Chart 
 
 
 
 
 
 
  
23 
 Figure 2: Qualitative Flow Chart 
              Mixed Methods Research Design 
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 3.13  Demographics 
Socio-demographic data was collected, including age, gender and highest level of 
education. In addition, each participant was asked to complete three surveys. The 
demographic group characteristics were limited to a few questions to protect the 
participants’ identity and safety. They were randomly selected to create equivalent and 
representative groups of different services, which were essentially the same in 
matching the variables of the inclusion criteria of Data Protection Act (1998).  
3.14 Data Collection Methods 
3.14.1 Phase 1 – Quantitative Methods 
Three study measures were used to score changes in participants’ skills capability, self-
efficacy and attitudes to RPMC at Point 1, Point 2 and Point 3. 
3.14.1.1  Study Measures 
1) General Self-efficacy Scale (Appendix 8), which has established psychometric 
properties, was developed by Schwarzer (1993). It is a 10-item scale designed to assess 
optimistic self-beliefs to cope with a variety of difficult demands in life. It measures the 
belief that one's actions are responsible for successful outcomes. The questionnaire is 
short (10 items) and takes five minutes to complete. It is recommended that not too 
much time is spent on each individual statement.  
2) Leeds Attitude towards Concordance Scale (LATCon) (Appendix 9) (Thistlethwaite et 
al., 2003) describes the psychometric properties of the LATCon, which is used to 
measure attitudes of nurses towards patients and MC. However, a small adaptation was 
made to the LATCon scale by substituting the term ‘nurse’ for ‘doctor’ and ‘service user’ 
for ‘patient’ in the current study. It consists of 12 items, each scored on a four point 
Likert scale and thus the range of scores is 12–36. An item score of 2–3 means that the 
participant agrees with the principle of concordance. 
Permission was obtained from the authors of the Self-efficacy and the LATCon 
questionnaires (Appendix 10), included in the frequency distributions in the next 
chapter.  
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 3) The Skills Capability Questionnaire (Appendix 11) was designed for this study to 
measure the content of the RPMC course. To date, no work has taken place to measure 
its psychometric properties. A modified Likert scale of 1–5 was used, 1 being Strongly 
Disagree, 5 being Strongly Agree and 3 being Neutral. The scoring was analysed at 
Points 2 and 3 to find out if there had been a change in nurses’ attitudes towards MC. 
3.14.1.2 Data Analysis Methods 
The main analysis was to investigate changes at Point 1 and Point 3 to establish whether 
any change in nurses’ skills capability, self-efficacy and attitudes occurred as a result of 
the RPMC training.  
The data were analysed using the Statistical Package for Social Sciences (SPSS). Non-
parametric tests were used, in this case a two-tailed Wilcoxon Signed Rank Test (WSRT) 
that measures the strength, or otherwise, of ‘within-group’ changes. The WSRT was 
chosen because of the abnormal data distribution and the small sample size that 
required non-parametric testing. As this was a small sample, statistical power was not 
claimed as the effects are harder to detect in a small sample (Button et al., 2013). The 
Wilcoxon test was used for the within-group analysis because there were repeated 
measurements on a single sample to assess whether their population mean rank 
differed from Point 1, to Point 2 and Point 3. It also provided the median and range for 
comparisons, along with the P-value. For more details, see Appendix 12. 
3.14.2 Phase 2 – Qualitative methods 
In order to explore the impact of the programme and to gain further insight (Krefting, 
1991) into the ‘real practice world’, the five participants in this qualitative study were 
volunteers and, as it happened, they came from three different services. Consequently, 
views obtained of the impact of RPMC in practice were broadly realistic in the thematic 
analysis and integration phase of this study. 
When the participants had initially been recruited onto the study a specific question 
was posed as part of the consent procedure, asking the participants whether or not 
they were prepared to take part. The interval of 10 weeks was chosen, as to have 
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 integrated this with the administration of the surveys would risk the participants being 
influenced by their answers.  
3.14.2.1 Data Collection Methods: Qualitative Steering Groups 
This group was set up to devise the questionnaire and obtain accurate information 
relating to the level of knowledge, attitude, personalities and beliefs, or preferences 
(Leung, 2001). A small advisory steering group was chaired by a nurse consultant who 
had been involved with the project since its inception, along with the principal research 
applicant, an academic, a qualified nurse, a service user and a carer. It was convened 
following the programme to finalise the themes for the qualitative interview guide 
(Appendix 13).  
An interview guide was used, whereby the same questions with the same wording and 
in the same sequence were asked of all respondents (Corbetta, 2003). In other words, 
the interviewees were presented with the same context of questioning (Aboraya, 2009). 
The interviews of the focus group participants were conducted by two independent 
researchers, one to facilitate the discussion and a second to take notes regarding his or 
her interactions. To that effect, an interview guide was developed (Appendix 14) and 
finalised (Appendix 15) and training was provided to the interviewers to conduct the 
interviews in a systematic approach. The process was rehearsed until they felt 
sufficiently confident to conduct the interviews. 
3.14.2.2 Data Analysis Methods  
Following transcription, the transcripts were examined to extract themes using the 
framework set out by Braun and Clarke (2006). Thematic analysis (TA) is a method of 
identifying, analysing, reporting and interpreting various patterns or themes within the 
data (Boyatzis, 1998). The data were analysed in the following forms: interview 
transcripts; field notes; and audio recordings. Themes may be directly observed from 
data or may be seen at an underlying level. In this way it can be seen how the 
researcher made decisions on what I wanted to know from the data collected. 
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 In order to ensure quality assurance, a nurse consultant educated to doctorate level 
helped me to examine the transcripts to derive themes. Thereafter, we met to 
negotiate, and finally to agree them. 
Once the reflective quotes were received, I familiarised myself with them by going over 
them several times so that I could work out the themes emerging from the answers. As 
part of the TA, I devised a structure process with outcome measures leading to the 
persuasive theme. This structured approach included: Level 1 coded extract; Level 2 
merging themes; and Level 3 naming the themes. The analytic process described the 
various stages from the interviews leading to the framing of the themes. This included 
the interpretation of themes, summaries arising from each question and the themes 
emerging from each summary, before naming the final or critical theme. Finally, there 
was a discussion and presentation leading to the persuasive theme of this thematic 
analysis. All aspects of the thematic analysis are presented in Chapter 4, Part 2, which in 
turn forms part of the data integration. 
3.15 Data Integration – Qualitative and quantitative data 
The integration of the qualitative and the quantitative data took place in the 
interpretation phase of this study, with the purpose being to use the qualitative results 
to explain the quantitative findings. It is recognised that, whilst the results of both 
methods may differ, their primary purpose is to support each other (Walsham, 2006).  
As one method fits within another, this provided more insight into different levels of 
analysis (Tashakkori and Creswell, 2008). Another benefit of using such an integration 
technique was to increase my confidence about the validity of the results by testing 
alternative interpretations of the data that could shape the results. Quantitative and 
qualitative data may also be inconsistent with each other, in which case they can 
provide fresh insights into the outcomes of inquiry leading to the development of new 
knowledge for further research. 
This richness could not have achieved using a single method (Tashakkori and Teddlie, 
2003; Teddlie and Tashakkori, 2009). Tashakkori and Teddlie point out that divergent 
and complementary views can trigger deeper examination of the findings and therefore 
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 open the door to future enquiry, leading to a holistic view that RPMC may have on 
inter-relationships, skills, self- efficacy and attitude change at Point 3. 
Despite a robust design, any research method has its limitations; biases inherent in any 
single method may neutralise or cancel the biases of other methods. This is based on 
the notion that quantitative researchers attempt to eliminate bias, whilst qualitative 
researchers make an explicit acknowledgement of bias (Creswell, 2003). 
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 Chapter 4 Section 1 
4.1  Results of the Quantitative Data Analysis 
A brief overall description of the group demographics was presented. This is followed by 
the routine evaluation and analysis of the RPMC course as perceived by the participants. 
Due to the small sample size, only the medians and range values were used to measure 
the changes in skills capability, self-efficacy and the attitudes at different time points. In 
order to analyse any within-group changes in total scores, two-tailed Wilcoxon tests 
were computed and results of any significance findings presented. To conclude, the 
overall results of changes in measures of skills capability (SC), self-efficacy (SE) and 
attitudes (LATCon) at different points in time will be presented in diagrammatic form, 
followed by a discussion (see Sections 4.4 to 4.10 below). This is to help with the 
development and understanding of the changes that took place, and to enhance self-
reflection during the course of the quantitative analysis (Hay and Kinchin, 2008).  
4.2  Experimental Group Demographic Characteristics 
The total number of participants in the experimental group was 25. This cohort was 
comprised of 14 (56%) males and 11 (44%) females, with a range of 29–61 years and a 
median of 45 years. Participants had various qualifications: 15 (60%) were RMNs only, 
five (20%) had postgraduate MSc or MA, three (12%) had a Diploma in Higher 
Education, whilst two (8%) were operating as RMN specialists. 
4.3  Routine Relapse Prevention/Medication Concordance (RPMC) 
Course Evaluation  
The two-day RPMC training took place on two occasions as there were 25 participants in 
total and we could not accommodate them in a single room, so divided them into two 
groups. At the routine course evaluation, soon after the course ended, the participants 
were asked to answer 18 individual closed questions (Appendix 16). In addition, the 
participants were invited to make comments on four open-ended questions relating to 
the course itself. They were asked to tick their responses by choosing the appropriate 
number on a Likert scale of 1–5, with 1 being most negative and 5 being most positive. 
The results of the routine evaluation were presented in two parts: 
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 1. To find the mean, median, standard deviation and range of each question, along 
with an explanation for the lowest and highest scores, and 
2. To merge the answers of the participants in the form of text and to see the 
emerging themes and concepts that help to understand the scores of Q1–18. 
Table 1: Routine Relapse Prevention/Medication Concordance (RPMC) Course Data Analysis 
(Routine Feedback) 
Qs Do you have better understanding of: Mean Median SD Range 
1a Engagement  4.24 4.00 0.60 3-5 
1b The Relapse Prevention (RP) model  4.04 4.00 0.61 3-5 
1c High-risk situations  4.12 4.00 0.67 3-5 
1d Difference between lapse and relapse 4.28 4.00 0.68 3-5 
1e Early warning signs (EWS)  4.20 4.00 0.65 3-5 
1f Managing stress 4.00 4.00 0.65 3-5 
1g Managing faulty thoughts 4.00 4.00 0.76 3-5 
1h Rule-violation Effect (RVE) 3.92 4.00 0.64 3-5 
1i Developing a lifestyle balance 3.92 4.00 0.75 2-5 
1j Problem- solving 4.04 4.00 0.61 2-5 
1k Medication Concordance 4.36 4.00 0.64 2-5 
1l Assess medication non-concordance: 4.16 4.00 0.75 2-5 
1m 
Apply relapse prevention techniques in 
medication non-concordance 
4.12 4.00 0.88 2-5 
1n 
Measure the relapse 
prevention/medication concordance 
(RPMC) effectiveness 
3.92 4.12 0.76 4-5 
1o 
Was your interest sustained throughout 
the training 
4.28 4.00 0.68 3-5 
1p 
Would you recommend this course to 
others? 
4.60 4.00 0.75 3-5 
1q 
Would you recommend this trainer to 
others? 
4.36 5.00 0.50 3-5 
1r Overall, how would you rate the course? 4.32 4.00 0.70 4-5 
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 Table 1 shows the results of the routine feedback sheet that all participants were asked 
to complete at the end of the RPMC. These data relate to the study participants only. 
The average (mean) value is 4.16 (sum total of all the mean values divided by 18) and 
the average median value is 4.06 (sum total of all the median values divided by 18). This 
suggests the effects of the training were beneficial and valued, and that participants 
have a greater understanding of the concepts used in MC. The small SDs also indicate 
there was a minimal spread of data. The lowest mean scores (3.92) (17%) were in 
statements 1h (Understanding of RVE), 1i (Developing a lifestyle balance) and 1n 
(Measure the RPMC’s effectiveness) (16.7%) compared to the rest of the scoring at 
mean values between 4–4.6. Statements 1h, 1i and 1l (Assess medication non-
concordance) are relatively new concepts used in MC and therefore participants may 
not be familiar with them, which is the most likely explanation for the comparatively 
low mean values. 
4.4 Questionnaires and Data Analysis 
Initially, an analysis of the individual questions by the group was carried out. This was to 
ensure that, by comparing the scoring at different stages, a more complete picture of 
the development of participants might be formed. This meant analysis of the median 
and range values. In order to establish whether there were any within-group changes in 
total scores, two-tailed Wilcoxon tests were computed. On this occasion differences in 
median and range values are computed to take account of the small sample size.  
4.4.1  Changes in Total Skill Capability Scores 
These results are shown in Table 2. There was a significant difference between Skills 
Capability scores at Point 1 and at follow up Point 2 (Point 1) (n=21), (45, 30-58; 
Median, Range); (Point 2: (n=15) (52, 39-65; Median, Range) (p=0.002). Of greater 
import was the finding that there was a significant difference in Point 1 and Point 3 
scores; (Point 1) (n=21,) (45, 30-58; Median, Range); (Point 3) (n=1,) (56, 42-65; Median, 
Range) (p=0.001), as this indicates the improvement is maintained. There was no 
significant difference or strong evidence in scores between follow up at Points 2 and 3 
(p=0.444).  
Table 2 shows the changes in individual skills items over the study period. 
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 Table 2: Skills Capability Questionnaire Data Analysis  
Skills Capability Data Analysis Baseline (Point 1) Point 2 Point 3 
Q Statements Median Range Median Range Median Range 
2a Skills to engage with SUs in MC 4.00 2-5 4.00 3-5 5.00 4-5 
2b Skills to convey information on MC to SUs 4.00 2-5 4.00 3-5 5.00 4-5 
2c Skills to motivationally interview SUs to promote MC 3.00  2-5 4.00 3-5 4.00 3-5 
2d Skills to engage SUs in RP planning 4.00 2-4 4.00 3-5 4.00 3-5 
2e Skills to select appropriate techniques to promote MC with SUs 3.00 2-5 4.00 3-5 4.00 3-5 
2f Skills to select appropriate techniques to RP plan with SUs 3.00 2-5 4.00 3-5 4.00 3-5 
2g Skills to identify high-risk situations (HRS) of non-MC with SUs 4.00 2-5 4.00 3-5 4.00 3-5 
2h Skills to plan with SUs to improve their MC 4.00 2-5 4.00 3-5 4.00 4-5 
2i Skills to enable SUs to identify their EWS of non-concordance with their medication plan 4.00 2-5 4.00 3-5 5.00 3-5 
2j Skills to explore and manage stress, faulty thinking and Rule Violation Effect (RVE) with SUs as part of RP planning 3.00 2-4 4.00 3-5 4.00 3-5 
2k Skills to develop lifestyle balance with SUs as part of RP planning to support their plan for MC 3.00 2-4 4.00 3-5 4.00 3-5 
2l Skills to help SUs to plan an MC plan 4.00 2-5 4.00 3-5 4.00 3-5 
2m Skills to plan with service users an RP plan to ensure the implementation of their MC plan. 4.00 2-5 4.00 3-5 4.00 3-5 
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 Comparison of the group for the individual questions of skill capability at Point 1 of the 
RPMC course and at Points 2 and 3. 
4.5 Analysis of Skill Capability Median Scores 
The reader is referred to Table 2. 
Due to the small numbers and the number of variables, the quantitative analysis will 
concentrate on those changes between Point 1 and Point 3. 
There was an increase in medians against Point 1 and Point 3 for statements 2a, 2b and 
2i (Skills in engagement, with SUs in MC). This can mean an improvement in negotiating 
skills and inspiring confidence involving sharing information to SUs, and providing them 
with a more structured RPMC plan.  
There were no increases in medians for statements 2d, 2j, 2h, 2l and 2m against Point 1 
and Point 3 (Skills in management and planning in developing and improving SUs MC 
plan). As for questions 2d, 2g, 2h, 2l, and 2m, the median at Points 1, 2 and 3 were 
constant at the score of 4. Although the score points towards being beneficial and 
valued, there is a need to examine whether group or individual supervision and 
refresher courses can either sustain or improve this score over time. 
4.6 Changes in Total Self-efficacy Scores 
Table 3 shows statements that relate to individuals’ self-efficacy, beliefs and confidence 
in dealing with problem solving and coping abilities.  
Again, to establish whether there were any within-group changes in total scores, two-
tailed Wilcoxon tests were computed. There was a significant difference between Self-
efficacy scores at Point 1 and Point 2; (Point 1) (n=19,) (28, 18-40; Median, Range); 
(Point 2) (n=16,) (34, 26-40; Median, Range) (p=0.041). Of greater import was the 
finding that there was a significant difference in Point 1 and Point 3 scores; Baseline 
(Point 1) (n=19,) (28, 18-40; Median, Range); (Point 3) (n=15,) (35, 27-39; Median, 
Range) (p=0.026). This suggests the participants understand the use of RP concepts in 
MC. Furthermore, it indicates their skills, beliefs and confidence in understanding 
strategies used to engage and to motivate SUs to gain control over their medication 
increased after the RPMC course and that this improvement was maintained. Meeting 
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 the needs of the group through increased awareness, with demonstration to assess 
non-compliance of medication and the implementation of a methodical and structured 
plan met, was significant. Changes in individual item self-efficacy scores are shown in 
Table 3. 
Table 3: Self-efficacy Questionnaire Data Analysis 
Self-efficacy data Analysis Baseline (Point 1) Point 2 Point 3 
Q Statements Median Range Median Range Median Range 
3a 
I can always manage to 
solve difficult problems if I 
try hard enough 
3.00 1-4 3.00 2-4 3.00 2-4 
3b 
If someone opposes me, I 
can find means and ways to 
get what I want 
2.00 1-4 3.00 1-4 3.00 1-4 
3c 
It is easy for me to stick to 
my aims and accomplish my 
goals 
3.00 2-4 3.00 3-4 3.00 2-4 
3d 
I am confident that I could 
deal efficiently with 
unexpected events 
3.00 2-4 3.50 2-4 4.00 3-4 
3e 
Thanks to my 
resourcefulness, I know how 
to handle unforeseen 
situations 
3.00 2-4 3.50 2-4 3.00 2-4 
3f I can solve most problems if I invest the necessary effort 3.00 1-4 3.50 3-4 4.00 3-4 
3g 
I can remain calm when 
facing difficulties because I 
can rely on my coping 
abilities 
3.00 2-4 3.50 3-4 4.00 3-4 
3h 
When I am confronted with 
a problem, I can usually find 
several solutions 
3.00 2-4 3.00 2-4 3.00 2-4 
3i 
If I am in trouble, I can 
usually think of something 
to do 
3.00 2-4 3.00 2-4 4.00 2-4 
3j 
No matter what comes my 
way, I’m usually able to 
handle it. 
3.00 2-4 3.00 2-4 4.00 2-4 
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 4.7 Analysis of Self-efficacy Median Scores 
There were changes between Points 1 and 3 and increases in median ratings for 
statements, 3b, 3d, 3f, 3g, 3i and 13j (statements relating to problems, confidence, self-
belief in problem solving, coping abilities and confidence in dealing MC). These 
improvements in self-efficacy suggest a change in approach to their practice, ability to 
gain SUs’ confidence in taking control of their medication and to help them to solve 
other problems such as side-effects of medication, finance and housing. The changes 
seemed to happen because of regular contact with course participants discussing issues 
relating to MC and also providing them with literature materials to facilitate their own 
progress in practice.  
There was no change in medians between Point 1, Point 2 and Point 3 in statements 3a, 
3c and 3h (statements that relate to group participants self- beliefs and solving 
problems). This suggests they believe in their own self-efficacy, but not wholeheartedly, 
and those three areas need to improve. This may be due to a lack of knowledge and 
experience in dealing with unexpected problems such as cultural issues and the conflicts 
of using drugs and alcohol rather than their prescribed psychiatric drugs.  
Statement 3e (Handling unforeseen situations) showed an initial increase in medians at 
Point 2 and then a decline at Point 3. The participants believed they were able to solve 
unforeseen problems a week after the course, but over 8 months there was no further 
improvement in their self-efficacy due to possible barriers of putting MC into practice. 
Statement 3b (Opposition, conflict, confidence and self- efficacy) showed the largest 
increase in median ratings between Point 1 and Point 2, but no further increase at Point 
3. The reason for this is unclear. Statements 3i (Self-belief in getting out of difficult 
situations) and 3j (Confidence in handling difficult situations) did not show an increase in 
median rating until Point 3. This suggests that there had been a period of reflection and 
increase in experience to improve practice and, as a result, growing confidence and 
belief in dealing with personal matters relating to MC.  
36 
 4.8 Changes in Leeds Attitude towards Concordance (LATCon) Total 
Scores 
The median and range values are computed in recognition of the comparatively small 
sample size. There was a significant difference between LATCon scores at Point 1 (n=20) 
(45, 35-59; Median, Range) and at Point 3 (n=17) (53, 42-60; Median, Range) (p=0.007). 
Changes in individual items Leeds Attitude scores are shown in Table 4 
Table 4: Leeds Attitude towards Concordance Scale (LATCon) Data Analysis 
LATCon Data Analysis Baseline (Point 1) Point 3 
Q Statements Median Range Median Range 
4a Nurse-SU consultations should be viewed as negotiations between equals 4.00 3-4 4.00 2-5 
4b Nurses should respect SUs personal beliefs 4.00 2-4 5.00 2-5 
4c 
The best use of medicine is when it is what 
the SU wants and when it is likely to achieve 
the desired results 
3.00 2-5 5.00 3-5 
4d 
Dispensing medication can be viewed as an 
experiment carried out SU under the 
guidance of the prescribing doctor just as 
taking medication is an experiment carried 
out by patients 
3.00 1-4 3.00 1-5 
4e 
Nurses should allow SU to discuss their 
thoughts and feelings about their illness and 
how it should be treated 
4.00 3-5 5.00 3-5 
4f 
Improved health would result from co-
operation and mutual respect between 
nurses and patients 
4.00 2-5 4.00 3-5 
4g It is important that nurses and SU establish an agreement about the need for medication 4.00 3-5 5.00 4-5 
4h 
Nurses should take account of SU’s needs, 
desires and abilities when discussing 
medication 
4.00 3-5 5.00 4-5 
4i 
The most important decision during the 
nurse-service user’s consultation is that of 
the patient 
4.00 3-5 5.00 3-5 
4j 
Nurses should be more sensitive to the 
reactions of service user towards information 
given regarding their treatment 
4.00 2-5 4.00 3-5 
4k Nurses should learn about the beliefs held by service user about their medication 4.00 3-5 5.00 4-5 
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 4.9 Comparison of the Group for the Individual Questions of LATCon 
Questionnaire Data Analysis at Points 1 and 3 
4.9.1  Analysis of LATCon Median Scores 
Statements 4a, 4f, 4j, and 4d that relate to Attitude change in consultation/negotiation, 
co-operation with respect to patient centred approach and perceptions by SUs viewing 
taking medication is an act of experimenting by them all saw no increase in the median 
rating at between Point 1 and Point 3. However, it must be noted that, with the 
exception of 4d, the Point 1 median was high anyway. Statement 4c (Meeting patients’ 
expectation) underwent a major jump in median between Point 1 and Point 3, 
suggesting that staff views changed notably as a result of training at eight months 
follow up. Eight of the 12 variables (66.7%) areas showed an increase in the median 
rating, which suggests a change in attitude towards MC. 
4.10 Changes in the Skill Capability, Self-efficacy and (LATCon) Scores 
In this case the mean scores of the Skills Capability, Self-efficacy and LATCon 
questionnaires were plotted on a graph (Figure 3). It clearly shows that the mean scores 
rose in all three independent variables at three time points, with the exception of the 
LATCon scores measured at Point 1 and Point 3. It must be noted that some data were 
missing in the administration of questionnaires at Point 1, 2 and 3. The statistics are 
shown in Table 5. The tendency is for all the changes to occur at Point 2 (where 
relevant). The skills scores show a small non-significant change between Point 2 and 
Point 3 (p=0.444); in contrast the change in self-efficacy score between Point 2 and 
Point 3 is significant (p=0.05).  
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 Figure 3: Study Measures over Time 
 
Table 5: Study Measures over Time           
 Point 1 Point 2 Point 3 
 Mean SD Mean SD Mean SD 
Skills Capability 44.71 7.80 53.87 7.00 56.24 6.45 
Self-efficacy 28.26 6.11 32.69 4.51 34.33 3.70 
Leeds Attitudes 45.70 7.24   52.76 5.44 
 
Self-capability Point 1: n= 21; Point 2 n=15, Point 3 n=15. 
Self-efficacy Point 1: n=19; Point 2 n=16; Point 3 n=15 
LATCon Point 1: n=20; Point 3 n=17 
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 4.11 Summary 
The findings from the quantitative data were presented in text and diagram format to 
highlight significant changes in RPMC evaluation, and changes in skills capability, self-
efficacy and attitudes at different time intervals. 
The mean, median values and SD all pointed towards the RPMC course as being 
beneficial to the nurses in skills acquisition, self-efficacy and attitude changes. This led 
to significant improvement in their skills capability scores at Point 1 and Point 3; 
p=0.001, but no significant difference at Point 2 and Point 3, p=0.444. Similarly, there 
was also a significant difference in self-efficacy scores between Point 1 and Point 3 
scores, p=0.026, with a noteworthy significant difference in scores between Points 2 
and 3; p=0.05. The difference in LATCon scores at Points 1 and 3, p=0.007 was equally 
significant, supported by the fact that eight of the 12 (66.7%) areas showed an increase 
in the median ratings, suggesting a change in attitude towards MC. 
The data suggest that the improvement in attitude is maintained at eight months. 
However, it is important to remember that this variable was not assessed at Point 2. 
The changes in the other variables are of note. The self-efficacy scores improved from 
baseline to Point 2, and from Point 2 to Point 3. This suggests that the improvement in 
self-efficacy is maintained over the eight month period. In contrast, the improvement in 
skills and knowledge took place largely in the early part of the study; although there is 
an improvement in scores between Point 2 and Point 3, it is not significant. This 
indicates that booster sessions in skills and knowledge may be beneficial. 
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 Chapter 4 Section 2 
4.12 Background  
For the purpose of the qualitative study, investigation of the views of nurses about the 
changes on their skills, self-efficacy and attitudes by thematic analysis (TA) was 
conducted. Five participants from the focus group were interviewed 10 weeks after the 
RPMC course. Their interviews were audio recorded and then transcribed. This was 
followed by the TA of their individual responses reflecting their views, experience, 
knowledge, skills, attitudes and effects on their career. They were asked if they wanted 
to contribute anything towards the research questions. Each participant was asked to 
indicate agreement with questions (Appendix 17) by answering either ‘yes’ or ‘no’. This 
was followed by an open-ended question where reflective quotes by participants were 
taken for the TA using an adaptation of Braun and Clarke’s (2006), six-phase guide. 
4.13 Why Braun and Clarke? 
Methods used to identify and interpret respondent views by TA can be complex, for 
instance using inductive techniques such as grounded theory, designed to identify 
categories and concepts within the text (Lingard, 2008). Currently researchers 
acknowledge there is no best specific method, but that there are different tools used 
across different methods in TA (Holloway and Todres, 2003). Braun and Clarke’s work is 
well researched and has been used by researchers over two decades. Their model 
provides a core flexible approach with examples of the application of TA and good 
theoretical backing, including use of their own experience. This enabled me to account 
for the ‘hows’ and ‘whys’ of doing this TA in a clear, consistent and coherent manner 
(Thomas and Harden, 2007), making my own assumptions to provide a persuasive 
argument for my findings.  
4.14 My Approach to Thematic Analysis 
Being a novice in TA, I had to make sense of the reflective quotes through structure and 
process to eventually name the theme. The initial process, as illustrated in Figure 4 
below, was to examine the best way to begin this analysis, which required:  
The initial mapping of the stages from the data corpus to naming the end theme (all 
concepts are explained below),  
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 Data Corpus: All interview data x 5 
Data Set: Data used for analysis only 
Data Item: Quotes - Typed text of interviews 
Coded Extract: Themes from quotes (Level 1) 
Merging Themes: Themes from quotes (Level 2), and 
Naming the Theme: Contextualising the combination of all the meanings extracted from 
the themes (Level 3). 
Figure 4: The Structured Approach to Thematic Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.14.1 The Thematic Analysis Process 
From the quotes collected from the interviews of the five focus group participants, it 
was obvious that analysis of the transcripts was complex, and grouping responses from 
individual questions enabled me to remember and familiarise myself with the data 
(Appendix 18). From there, I inserted the data in a table format with my interpretations 
of the meaning of the quotes. This was followed by a summary of my overall 
Based on Braun and Clarke, 2006 
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 interpretation of the questions. This process was repeated for the other five questions. 
After completing that task, I was able to analyse and detect any patterns in the views of 
the participants that would require further investigation.  
My initial interpretation was that respondents’ answers to the questions were in 
general similar, but that the way they described them and the examples provided were 
different. In that context, I felt reassured that they were accurately describing their 
experiences and, as they worked in different services, it was unlikely that they had been 
able to discuss their responses as a group in order to present similar answers to the 
questions. In this case, validation of their approach to the thematic analysis was not in 
dispute. This process is illustrated in Figure 5 below. 
Figure 5: Thematic Analysis Process  
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 This exercise proved extremely useful in that I was able to start thinking and reflecting 
on themes that were beginning to emerge. Initially, I thought the identified themes 
were persuasive, but this was found not to be the case. I had to go backwards and 
forwards over them, often changing the names of the themes, to make sure that I was 
on the right track to support my research question. This process was revised many 
times before saturation point was reached, where I could not go any further in 
substituting the final theme with another word or words. 
The outcome of this process is illustrated in Figure 6, below. 
Figure 6: Thematic Analysis Outcome, based on Braun and Clarke, 2006 
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 Chapter 4 Section 3 
4.15 Thematic Analysis Outcomes 
4.15.1 Participants and Demographics 
There were three male (E9, E39 and E22) and two female (E20 and E21) participants. 
The mean length of experience, following qualification of participants, was 8.8 years 
(range 30–53 years). Of the five participants, one had a Higher Diploma, one had a 
degree and one had a Master’s degree. At 10 weeks after the RPMC course, the five 
respondents were interviewed and their responses analysed.  
Following the analysis of the transcripts as detailed in Chapter 4 Part 2, six themes were 
seen to emerge: 
• Awareness of changes 
• Practice dilemmas 
• Ownership of aptitude  
• Psychology of thinking  
• Satisfaction  
• Hopefulness. 
4.15.1.1 Number 1: Awareness of change 
Respondents identified their awareness of change to their way of working with patients, 
with one respondent stating how she worked differently by being able: 
to change approach to a more structured, methodical way and therefore 
implementing things better now. (E21) 
Another respondent focused on how he was able to improve the way in which he 
engaged with patients in a more open dialogue on specific and personal issues by being 
able to: 
Increase my knowledge and skills to become more resourceful in dealing with 
complex issues such conflicts between using drugs and alcohol instead of 
their prescribed medication. (E39) 
On this occasion, a CPN was able to use concepts of RP as a way to improve 
engagement with his patients by showing a ‘greater understanding of EWS’ and 
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 ‘increased negotiation skills to inspire confidence through motivating them (patients) to 
take their medication’ (E22). 
Another respondent focused more on changing the culture of her service by introducing 
a ‘medication concordance clinic’ where she was able to engage with patients dealing 
with their medication issues, so that ‘we can share our opinions and views in a 
respectful way’ and discuss the ‘therapeutic benefits of medication also any side-effects 
or problems, etc’ (E20). 
This particular respondent saw awareness of change in assessment and problem solving 
by being ‘more aware of the problems with MC’ and ‘being able to develop my skills 
with SUs whilst giving information about their medications’ (E9). 
It can therefore be seen, following the RPMC, that respondents were able to identify a 
range of ways to use what they had learnt in order to enhance their practice. This 
included using a more systematic approach, dealing with complex issues, being 
innovative and sharing of information better with SUs.  
4.15.1.2 Number 2: Practice Dilemmas 
The respondents saw barriers to implementing RPMC in practice in a variety of ways. 
One CPN identified difficulties due to an ‘increase caseload and large volumes of 
paperwork and documentation’ (E20). Another CPN saw the effects of this increase in 
caseload resulting in ‘not having enough time during the day to fully implement, 
monitor and to review the effects of their (patients’) medication’ (E22). 
Another respondent felt an absence of supervision to support RPMC had created 
difficulties having ‘to work with patients, who are adamant not to take their medication 
because of their culture and religion’ (E39). Similarly, one nurse saw that, without 
academic support, she envisaged ‘difficulty will also arise when it comes to put MC in 
practice after learning such a lot on the course’ (E21). 
Another respondent felt that lack of support could hinder his professional practice. He 
explained, ‘We need updates, supervision and time to reflect of where we go wrong and 
lessons to learn from our colleagues when they get things right’ (E9). 
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 As shown above, the respondents identified a range of barriers, in particular the 
increased caseload, its effects on RPMC and SUs and a lack of support and time 
available for reflection to improve MC. 
4.15.1.3 Number 3: Ownership of Aptitude  
The respondents showed a readiness for quick learning by demonstrating their 
individual approach in a variety of ways; one CPN identified his aptitude had changed to 
‘being more empathetic towards the patients’ (E39). 
 On the same issue, another respondent recognised she thought that she did not have 
the aptitude to talk to carers about RPMC but had now changed, being able to ‘Listen to 
carers now more than before and feels more confident to answer their questions’ (E21). 
Lack of confidence to engage with his patients led another nurse to change by 
improving his ‘negotiation skills to increase SU’s confidence and motivation levels in order to, 
understand SU’s capacity, choice and control’ (E22).  
In order to engage on issues of cultural differences not previously addressed, another 
respondent is now able to recognise the link between religion and mental health by 
being able to talk ‘about their religious and cultural backgrounds and impact this can 
have on someone’s mental health’ (E20). 
It can be seen at 10 weeks following the RPMC that the respondents were able to show 
change in aptitudes in a variety of ways, by an increase in their listening and negotiation 
skills whilst also showing more empathy towards SUs and dealing with issues such as 
their religious and cultural needs.  
4.15.1.4 Number 4: Psychology of thinking  
The respondents have shown changes in their cognitive capabilities in different ways to 
effect their personal approach to enhance MC. As one CPN implied, his, 
knowledge and skills has become more resourceful in dealing with complex 
issues such conflicts between using drugs and alcohol instead of their 
prescribed medication. (E39) 
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 Another respondent found her cognitive approach to SUs’ care plans had improved in a 
pragmatic way by being able to ‘explain to clients it’s very important to take 
medications and explaining to them about their medications and interventions to 
improve their mental health’ (E21). 
Selected psychological concepts taught on the RPMC course were used by one CPN in 
responses to SUs’ needs, ‘understanding EWS had increased my dialogue with my 
patients and had increased my confidence through motivating them to take their 
medication’ (E22). 
In order to improve his assessment skills, another respondent gave a different example 
of a psychological concept: being able to ‘work with their faulty thinking such as the 
tablets they are being given are poisoning their brains and body’ (E9). 
To ensure independent decision making regarding medication, another nurse found she 
is now able to offer counselling to SUs by ‘advising people and making sure they have 
the autonomy and in making sure they’re given as much choice as possible’ ( E20). 
From the above persuasive arguments, it can be seen that respondents have improved 
their cognitive, affective and behavioural capabilities. Since the RPMC course, the CPNs 
are working more skillfully in identifying psychological concepts taught on the course 
and to offer choices and interventions to improve MC and autonomy among SUs.  
4.15.1.5 Number 5: Satisfaction  
The RPMC triggered a sense of a ‘feelgood factor’ among the respondents. On 
reflection, one respondent changed his behaviour in being motivated to ‘read more on 
RPMC now to increase my knowledge and skills to become more resourceful in dealing 
with complex issues’ (E39). 
Similarly, another respondent conveyed a sense of achievement through ‘Increasing 
negotiation skills to inspire confidence through motivating SUs to take their medication’ 
(E22). 
On a different notion, a respondent felt quite proud of her achievement in introducing 
and running the first MC clinic in the Trust: ‘I think it was triggered by me and I can now 
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 offer better explanation and education to SUs regarding positive and negative aspects 
of medications’ (E20). 
It can be seen that the RPMC had positive effects in a range of ways, as the respondents 
felt satisfied and grew in confidence and motivation to improve MC.  
4.15.1.6 Number 6: Hopefulness 
The respondents showed signs of optimism in different contexts to enhance RPMC; one 
respondent saw it as a potential to improve his continuing professional development 
and realised that with ‘a reality check I have got a long way to go to be competent in 
RPMC but I feel I am getting there but not all there yet’ (E9). 
Another CPN expressed her views of sustaining RPMC in practice and she recommended 
that ‘clinicians need to be more flexible rather than dictating to clients and to present a 
more balance information to them’ (21). 
When working with non-adherent patients, a respondent concurred that RPMC can be a 
potential asset in that: 
nurses may develop more insight as to why SUs are not compliant with taking 
medication and become more resourceful in dealing with complex issues in 
MC. (E39) 
From personal expectation, another respondent felt that applying RPMC in practice 
could enhance his reputation to be a:  
role model within the service and promote the positive outcomes of the 
model in challenging circumstances and within a high service provision. (E22) 
Following the RPMC course, the respondents have shown optimism over improving and 
sustaining RPMC in different ways by reflecting how lessons learnt from the course 
could be of benefit to their own professional and practical development. 
4.15.1.7 Capability to help 
From the above six themes and arguments, I have been persuaded to believe the 
overarching theme of ‘capability to help’ is appropriate. This theme is quantified by the 
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 respondents being able to demonstrate an improvement in their intuitive capabilities to 
enhance MC with their patients.  
In the next chapter, there will be a presentation of how the quantitative data and the 
qualitative data integrate, and whether they support each other or not. 
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 Chapter 4 Section 4 
4.16  Integration of Quantitative and Qualitative findings 
The integration of quantitative and qualitative findings in this chapter ascertains 
whether they confirm or confound each other in the three study measures of:  
• Skills capability, 
• Self-efficacy, and  
• Attitudes. 
4.15.2 Skills Capability  
From the quantitative data of the skills capability measures, the increase in median 
scores for statements 2a, 2b and 2i, ‘Skills in engagement with SUs in MC’ at Point 1 and 
Point 3 (4.00-5.00) were confirmed by the qualitative data for responses by three 
respondents, with one participant feeling that after the RPMC he was able to, ‘Increase 
negotiation skills to inspire confidence...’ (E22). Another nurse felt more resourceful in 
being able to ‘develop my skills with SUs whilst giving information about their 
medications and to be more aware of the problems with MC’ (E9). Another CPN 
indicated that she had improved her skills capability by expressing the ‘need to engage 
in a very therapeutic way with the clients and to know their views’ (E21). 
The quantitative data for statements 2d, 2g, 2h, 2l and 2m relating to ‘Skills in 
management, planning, developing and improving SUs MC plan’ were constant at the 
median score of 4, and this data was also confirmed in the qualitative data by responses 
from respondents who were working towards improving themselves in those areas. 
Providing RPMC to all SUs was a challenge to one respondent, in having to ‘offer RP 
techniques to every patient especially when they are either not well or not taking their 
medication’ (E20). In the same context, another participant found responding to 
patients’ RPMC needs difficult when ‘dealing with quite a lot of clients in the community 
with complex cases more skillfully and offer more alternative choices if possible to 
improve MC’ (E39). 
It can be seen therefore that the quantitative was confirmed by the qualitative data in 
skills capability measures. 
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 4.15.3 Self-efficacy  
There was an increased change in median scores at Point 3 for statements 3b (2.00–
3.00), and 3d, 3f, 3g, 3i and 13j (3.00–4.00) relating to ‘self-belief in problem solving, 
coping abilities and confidence’ in MC. Responses to those variables have shown a 
range of approaches by the interviewees. Following RPMC, one nurse was able to apply 
his improved knowledge and skills to ‘have a better understanding of what MC is about 
and to offer more alternative choices’ (E9). Another respondent demonstrated that his 
approach to MC had improved by being able ‘to inspire confidence through motivating 
them (patients) to take their medication’ (E22). In order to deal with a specific issue, 
after RPMC one nurse is coping better by becoming ‘more resourceful in dealing with 
complex issues such conflicts between using drugs and alcohol instead of their 
prescribed medication’ (E39). It can be seen therefore that the quantitative data 
confirms the qualitative data for the above statements. 
Statement (3e), that relates to ‘unforeseen problems’ in the overall quantitative data, 
showed an initial increase in median scores at Point 2 (3.00–3.50) and a decline at Point 
3 (3.50–3.00). To that effect, responses from the following respondents’ statements of, 
‘I now have a better understanding of what MC is about’ (E9), ‘with my cultural 
background, I can explain to clients (with similar backgrounds) why it is very important 
to take medications... (E20) and, ‘to provide them with a more structured approach, 
(E39). These statements suggest the respondents’ self-efficacy was still maintained at 
10 weeks post-RPMC thus confirming the quantitative data. However, beyond that 
point, it was difficult to provide an answer to the decrease in median score. The only 
plausible answer could be a lack of support, supervision, updates and time to reflect on 
RPMC, as indicated by the respondents in the ‘Problem Dilemmas’ section of the 
previous chapter.  
Conversely, statements 3i, ‘Self-belief in getting out of difficult situations’ and 3j, 
‘confidence in handling difficult situations’ did not show an increase in median rating 
until Point 3, (3.00–4.00), when the respondents showed they were still in the 
contemplation stage of handling difficult situations at 10 weeks post-RPMC although 
they were becoming ‘more aware of the problems with MC...’ (E9) and also in ‘dealing 
with complex issues...’ (E39).  
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 It can be seen, therefore, that the quantitative data confirm the qualitative data at 10 
weeks post-RPMC. However, the increase in median score at Point 3 may be due to the 
respondents being aware of routine difficult problems and were reflected in improving 
their self-efficacy and confidence in these areas, thus confirming the quantitative data. 
4.15.4 Attitude Changes  
After RPMC, respondents showed a change in attitudes in a range of ways, highlighted 
particularly in the ‘Awareness of Changes’ section of the previous chapter.  
Statements 4a, 4f, 4j, and 4d in Table 4 (Chapter 4, Part 2) that relate to attitude change 
in consultation/negotiation and co-operation with respect to patient-centred approach 
showed no increase in the median rating between Point 1 and Point 3 (4.00) . 
On several occasions respondents attitudes changed in, ‘Increasing negotiation skills to 
inspire confidence through motivating them (patients) to take their medication’ (E22); 
‘we can share our opinions and views in a respectful way’ (E20) and ‘to change 
approach to a more structured, methodical way and therefore implementing things 
better now’ (E21). They also showed to become ‘more responsible in whole treatment 
and giving them (SUs) opportunity to say their opinions about medication’ (E9) and 
‘feeling more skilful and positive to deal with my patients...’ (E20). Therefore, it can be 
seen the quantitative data has confirmed the qualitative data for statements 4a, 4f, 4j, 
and 4d.  
Statement 4c (Meeting patients’ expectation) showed a very large jump in median score 
(3.00-5.00) between Point 1 and Point 3. From the qualitative data, and the quote 
above, the respondents have shown they were listening, negotiating and finding better 
ways to work with SUs in MC as one respondent said, ‘so I do listen to them now when 
they say they don’t want to take it (medication)’ (E21). It can be seen, therefore, that 
the quantitative data confirm the qualitative data for statement 4c. 
In eight of the 12 variables (66.7%), statements made by respondents’ attitude towards 
MC, in respect of ‘Consultation, negotiation and ability to meet SUs expectations 
including beliefs held by them’ showed an increase in the median (4.00–5.00) with the 
exception of the median score for statement 4c (3.00-5.00). In that context, the 
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 respondents have shown a change in attitudes in these areas in many ways, as 
highlighted below. 
‘I now have a better understanding of....’ (E9)  
‘to act as advocate to carers’ (E22) 
‘to change approach to a more structured, methodical way... now; more 
aware that we need to engage in a very therapeutic way with the client, to 
know their views... and to see from their own perspective... how they feel 
about their medication’ (E21) 
‘to share our opinions and views in a respectful way... and I can explain to 
clients (with similar backgrounds) why it is very important (E20).  
From these responses, it can be seen that the quantitative data confirm the qualitative 
data. 
4.17 Summary  
First, the quantitative data confirm the qualitative data in this chapter of the three 
study measures of skill capability, self-efficacy and attitude towards RPMC. Secondly, 
this approach has tested the validity of the results by testing alternative interpretations 
of the data that shaped the results. These include areas such as, ‘unforeseen problems’ 
and in ‘Handling difficult situations’. Finally, the mixed method results point out 
divergent and complementary views, that is, different approaches to RPMC, through 
deeper examination of the findings. This has led to a holistic view of RPMC in the inter-
relationship between skills capability, self-efficacy and attitude changes at 10 weeks and 
at Point 3. 
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 Chapter 5  Discussion and Conclusion 
The outcome of the study into the effects of the RPMC on CMHNs showed ‘within-group 
changes’ in the quantitative scores, with significant changes in skill capability, self-
efficacy and attitude at eight months follow up. The emerging themes from the 
qualitative results explained, supported and complemented the quantitative results and 
were consistent with each other. As a result, a ‘second phase’ data collection is 
currently underway to evaluate the longer-term outcome of this study. 
The findings from this project suggest that the nurses benefitted from the person-
centred and proactive nature of the ‘evidence-based structure and content’ of the 
RPMC programme. It is therefore plausible that patients’ care in MC will improve with 
better engagement through information sharing enhancing their overall wellbeing and 
their relationship with their illness and medication (Byrne et al., 2008; Jagessar, 2008), 
in turn reducing relapse rates. 
5.1 Methodological Limitations 
Little research has been carried out into the success of nurses’ interventions in MC or 
the best training for them and the effects on SUs. This limits the literature review 
underpinning the study. However, it also highlights the need for more comprehensive 
studies into RPMC to explore this potentially beneficial intervention. 
In this study, nurses’ own past experience, skills, knowledge and attitudes towards MC 
were not taken into account and therefore these positive outcomes may be subject to 
confounding influences.  
Within the resources allocated to the project it was not possible to have a control group 
to compare the effects of RPMC with routine nursing interventions and, therefore, the 
true effects remain untested.  
Another limitation was the small sample size and therefore lack of statistical power to 
detect clinically important effects (Suresh and Chandrasekara, 2012), but this was 
compensated for by having a more robust design in the selection of the sample and the 
mixed methods triangulation. The results from a larger sample size would be more 
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 conclusive but, in having to expose a larger number of subjects to the procedure, it 
would be more costly.  
The convenience sample was chosen to have some degree of control with accessible 
facilities and data collection (Skowronek and Duerr, 2009). Thus, the study could have 
benefitted from a variety of differences and agreements of the participants’ views, 
experience, skills, and knowledge (Hedt and Pagano, 2011). 
Compared to the self-efficacy and attitude scales, the skills capability tool did not have 
established psychometric properties. This means a validated tool to measure skills 
capability of RPMC is required for future studies. 
The CPNs engaged well in the qualitative interviews and were able to identify a number 
of challenges when implementing RPMC, including time limitations, and patients’ hard-
held beliefs and views about their medication. 
Time limitations have been associated with difficulties implementing new and evidence-
based interventions such as RPMC (Sin and Scully, 2008), therefore it is not surprising 
that the CPNs experienced similar issues. However CPNs may choose a more pragmatic 
approach by using RPMC with responsive patients (Brown et al., 2013). 
RPMC training did not focus on knowledge about pharmacology, therefore CPNs may 
not have the confidence to deliver medication management and discussions effectively 
(Byrne and Dean, 2011). This omission ought to be considered in future RPMC training. 
Missing data have not been taken into account in this study, therefore the overall 
outcomes cannot be assumed conclusive (Jackson, White and Leese, 2010). This is 
further compounded by the study measures being self-reporting; although nurses said 
their behaviour changed, the outcomes cannot be claimed as factual because this is not 
what was measured or observed. 
All these limitations point to the need for a randomised control trial with a qualitative 
component that can account for intervening variables and verify an improvement in 
skills capability, self-efficacy and attitudes of not only nurses but healthcare 
professionals, as well as SUs and carers. 
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 5.2 Procedural Difficulties 
The original proposal for completion of the study was three months but, because of the 
sickness and holidays of the two assistant researchers, it was difficult to take alternative 
measures and no other resources were available. A broader view of the participants’ 
experiences on other aspects of their clinical practice was not explored due to the 
inexperience of the research assistants conducting the interviews. These untapped 
views could have provided a more critical insight into this study, which potentially could 
affect future clinical nursing management in MC. 
5.3 Implications for Mental Health Nursing Education/Training and 
Practice 
RPMC could provide a framework that might have cost-effective benefits for the NHS, 
SUs, carers and others in contact with MH services. Equally important is to change the 
existing service delivery in line with modernising change in the NHS (Cameron, 2011) 
that advocate that nurses will continue to play a vital role. In RPMC it is more likely that 
nurses will see an improvement in MC as a core vocational responsibility (Coombs et al., 
2003). The RPMC training has been designed with a simple didactic, interactive and cost 
efficient approach (Foster and Jumnoodoo, 2008) that everyone can understand.  
It is important to encourage more nurses to be trained in RPMC techniques and 
thereafter outsource these skills to other professionals and lay people including SUs, 
carers and members of the community. Theoretical training on RPMCs needs to be 
followed up with work-based practice and supervision in action. The ‘whole systems’ 
approach coined by Jumnoodoo et al. (2002) would, in the future, be led by service 
users and carers who will deliver the RPMC programme and draw upon their own 
personal experiences. 
If policy makers and commissioners decide the RPMC is a model that should be widely 
introduced into nursing and other professional practices, then a dynamic system of 
supervision is required, from a basic introduction of RPMC to more advanced academic 
levels. RPMC can also be offered to individuals, or in a series of group sessions through 
counselling, knowledge and skills training on MC, where the individuals can learn how 
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 to manage the relationship between their illness and the medication required to enable 
them to stay well and prevent them from relapsing.  
For those who choose distance learning, a range of computerised RPMC, tele-medicine 
and digital apps could be made available. Universities should also consider including 
RPMC programmes in their curriculum, some of which could be delivered by distance 
learning. Those interested in the subject might further their studies to degree, Master’s 
and Doctorate/PhD levels. Consequently, a cohort of experts would be available to 
make further contributions and provide consultancy support to clinicians, SUs and 
carers to improve their existing knowledge and skills to enhance MC. 
The RP protocol and training could also be cascaded via publications such as in-house 
magazines, local newspapers, peer-reviewed journals and be presented at conferences 
and workshops. 
5.4 Conclusion 
Whilst this study does not constitute a methodologically rigorous test, it is still a 
demonstration of the benefits of the RPMC education programme to nurses’ skill 
capability, self-efficacy and attitudes. However, it remains unclear whether the nurses’ 
knowledge, skills and motivation would remain improved after the eight months follow 
up.  
The overall outcome of this mixed method study of educational programme of RPMC 
has benefitted the CMHNs in their skills development, knowledge and confidence, 
which is transferable to patients and SUs to improve MC. In that context, this study has 
been effective in meeting the NICE recommendations (NICE, 2009b: 20) for the 
development of an ‘effective, equitable interventions to support adherence to 
appropriate prescriptions’ and to encourage ‘informed choice and shared decision 
making through cost-effective ways of communication’. 
Although this study indicates that more research is needed, it has also highlighted 
changes to service delivery and potential improvements for continuous professional 
development of CMHNs.  
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 Other recommendations arising as a result of this study are the need for changes in 
nurses’ education on MC to improve the competency of nurses in MC at informal and 
academic levels. The whole ethos of this study is to prevent relapse due to non-
concordance of medication and, by improving MC, the expectation is that relapse rates 
will be reduced, improving patients’ quality of life and cutting the cost of hospital 
admissions. Money thus saved can be redirected to other community services, where 
there is a shortage of resources to improve care. 
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 Appendices 
Appendix 1: Concepts used in RP 
Affect: The way we express ourselves through feelings and emotions. It can have a 
range of high to low emotional tones and range from pleasant to unpleasant feelings. 
For example, anger is an affect of high emotional tone along with unpleasant feelings, 
whilst depression has low emotional tone along with unpleasant feelings. Conversely, 
mania is seen as high tone and pleasant feeling. 
Attribution: The process of assigning causality to events around us. It is individuals’ 
attempt to make sense of their world when they do not have the full facts, 
consequently it relies on individual perception. For example, a client believes they 
cannot move forward in life to do things other people do because they have been 
diagnosed with mental illness, are seeing a psychiatrist and taking psychiatric 
medication. 
Cognitive behavioural: Psychological intervention that targets specifically thoughts, 
images, beliefs and behaviour. It is aimed at the treatment of delusions, hallucinations, 
depression and, most obviously, obsessive compulsive disorders. For example, a client 
who refuses to comply with medication could try a behavioural intervention such as 
crushing the tablet before swallowing. Cognitively, the same client could change their 
belief concerning the efficacy of medication by extending the trial period or agreeing to 
a blood test to prove prescribed compliance. 
Cognitive reframing/restructuring: The process of positively challenging and modifying 
thinking errors in a non-threatening way with clients. An example could be a client who 
has auditory hallucination about a car crash and then assumes they are going to die in 
the car crash. This client will benefit by thinking differently about the meaning of their 
hallucination.  
Cognitive: A human response to thinking, images and beliefs. It is a tripartite 
relationship involving one or more of these mental processes. For example, errors in 
rational thinking can interfere with problem solving, intrusive mental images can cause 
emotional distress, and faulty beliefs can lead to unrealistic appraisal of the situation. A 
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 practical example could be someone who experiences visual hallucinations, and who 
might believe they are being controlled by some other person and would then think 
that taking their medication does not really solve their problems. 
Coping response: People’s response to a high-risk situation in which they attempt to 
use previously learnt, cognitive and behavioural skills or techniques to avoid lapse or 
relapse. An example could be the client who has learnt the importance of a user 
support group and decides to follow the good example of other clients by attending 
their drop-in centre when they feel pressurised at home because of recent events. 
Craving: A recurrence of a thought process that, in the past, has lead to a desirable yet 
unhealthy behavioural pattern that after treatment is kept under control; for others it 
could easily get out of control if acted upon. A patient who is under section starts 
craving for another overseas holiday (previously a great experience) and thinks 
obsessionally about how to get off section and to pursue that course of action. 
Cue: Anything in the environment that triggers urges, cravings and seemingly irrelevant 
decisions, leading to potential lapse or relapse. For example, in the previous case, a 
client who is always craving to go on an overseas holiday may be triggered by a staff 
member who freely discusses their personal plan of going on holiday. 
High-risk situation (HRS): Breaking down of a resolution or a control situation, which 
may be due to inter- or intra-personal relationships or other factors in a person’s life. 
This may precipitate a lapse or a full-blown relapse. An example could be someone who 
has achieved a sense of control in dealing with problems associated with mental illness 
in day treatment, but who then goes home in the evening to a situation of high 
expressed emotion. As a consequence, this person may become vulnerable to a 
stressful situation, reject treatment, feel ’what’s the point’ and subsequently relapse.  
Lapse: A slight error or a slip, a temporary fall, a single event a re-emergence of 
previous habits, which may or may not lead to a relapse. 
Lifestyle balance: A balance that service users have learnt to maintain healthy 
behaviours by being able to recognise things they continue to do in order to sustain that 
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 life style. An example could be the improvement in someone’s social life in order not to 
go back to being withdrawn and consequently to relapse. 
Lifestyle interventions: Activities leading to correcting an imbalance in lifestyle. An 
example could be doing daily exercise to counteract weight gain due to medication side-
effects. 
Positive outcome expectancies: The anticipation of feeling better as the result of some 
course of action. An example could be the abuse of prescribed medication, e.g. the 
patient who is on a maintenance dose of 5mg valium then decides they will feel even 
better on 10mg valium and starts self-medicating without appropriate consultation. 
Rule violation effect (RVE): This is a term we use here as a replacement of the term 
‘abstinence violation’ effect because we feel it is more appropriate to mental illness. 
RVE is therefore used to signify breaking a resolution the client has made to him- or 
herself, such as medication compliance, abstaining from self-harm, not following 
command hallucinations, etc, resulting in feeling guilty and thinking the situation is out 
of control. The strength of RVE helps determine the probability of a full relapse. 
Seemingly irrelevant decisions (SID): A precursor to being exposed to the likelihood of 
falling into a trap leading to a high-risk situation. At the time the decision in itself does not 
seem harmful and can easily be defended, rationally or irrationally, but may signal a change 
of course away from a healthy behavioural pattern. An example, it could be someone who 
decides to stay up late one night and then oversleeps in the morning, causing them to miss 
an appointment with the psychiatrist to review their medication, something they have been 
contemplating in order to stop medication. In this case the client may go back to make 
another appointment or may stop their medication, leading to a lapse or subsequently to 
relapse. 
Self-efficacy: A person’s beliefs in his or her ability to carry out or succeed in a specific 
task. The focus is on helping the client to make the change in a problem area as, once 
the skills and confidence have been developed and rehearsed, the client should be able 
to overcome his or her difficulties either with minimal help or independently. An 
example could be a client who after rehearsal will be able to travel by bus 
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 independently. Improving self-efficacy with this task will promote self-efficacy in related 
tasks that require greater independence such shopping, banking and socialising. 
Self-monitoring: After developing RP skills through training, service users will be able to 
detect high-risk situations and their antecedents. An example could be in cases such 
paranoia and anxiety states, when service users may exhibit high levels of hyper-
vigilance to their environment. In this case the service user will be taught to transfer 
those skills to include themselves, to become aware of high-risk situations and their 
antecedents such as craving, urges, etc. 
Skill acquisition: A client who has gone through skill training after having the necessary 
information, knowledge and support in order to gain the skill required to perform a task. 
An example could be a client suffering from agoraphobia, who can now travel by public 
transport after having received a course and booster sessions of cognitive behavioural 
therapy. 
Social learning theory: This assumes that a new behaviour can be learnt simply by 
exposure to another person modelling that behaviour. In practice, once a skill has been 
learnt by copying the model it can be maintained with reinforcement. An example 
would be a staff member modelling socially acceptable behaviour such as speaking 
calmly when a client is upset, and raising their voice and then praising the client when 
they do the same. 
Therefore a corrective measure can resolve problems, which can be regarded as ‘not 
getting out of control’. A lapse can be seen as process, behaviour or an event. For 
example, someone who was managing well mentally may suddenly notice a change in 
symptomology in that they start becoming slightly more paranoid or depressed. This 
may or may not lead to an acute phase of disorder.  
Thinking errors: Any irrational thinking or belief, not supported by evidence, which is 
unhelpful to a person in managing their mental wellbeing. An example could be a 
female client who believes all her problem would disappear if she regains custody of her 
children who are in the custody of social services. 
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 Urge: A strong impulse to suddenly act without careful thinking, for example a patient 
who needs instant access to psychiatric services, suddenly booking a taxi or calling an 
ambulance and ending up at an A & E department.  
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 Appendix 2: Structure of RPMC 
Relapse Prevention and Medication Concordance (RPMC) 
This simple model helps service users to learn individual coping skills so they present for 
help at an early stage of relapse, mapping out and recognising the impact of early-
warning signs on their health. By taking an active role in managing their own conditions, 
service users may be able to help determine the most effective medication regime and 
understand the importance of maintaining contact with helping services. To achieve 
those aims nurses need to be trained in RPMC and eventually trained alongside service 
users and carers to enhance MC in a coordinated manner. 
The RPMC 10 Session Model 
Recovery and Relapse prevention can be undertaken as a general approach to work, 
open exploratory sessions, or individual or closed group structured sessions with 
homework. When working with service users, training in the therapeutic sessions covers 
the following areas: 
1. Engagement: The primary consideration is for the nurses to give primary 
consideration to the individual and family to engage in RPMC therapy on an RPMC 
programme. The expectation is for them to learn how to involve other individuals in the 
initial stage of engagement to highlight the benefits of RPMC and the feeling of the 
community within the group setting, thus enhancing the benefits for all.  
2. Introduction to the model: An initial session explains the RPMC model to clarify how 
this simple but useful model can help nurses, individuals and families. It covers the 
expectations of the service user and the people delivering the education and training. At 
this point, the nurses on the programme will learn of the requirements to formalise 
commitment of all parties involved by a signed agreement, suggesting willingness to 
participate in the RPMC training. 
3. Understanding the ideas of lapse and relapses: A session to clarify that health 
deterioration is usually a staged process, where rarely are people simply ‘well’ and then 
‘unwell’. It is an important session for clients to appreciate the power of this fact, i.e. that the 
stages are opportunities for action; to reverse where possible an otherwise trend towards 
a return to illness or to undesired states. It is also an opportunity to explore with the 
client previous relapses, the precursor lapse, and to begin to put together the relapse 
repertoire. 
4. Identifying High-Risk Situations: The is a stage for identifying those circumstances 
that stress the client, which may be associated with reccurrence of an illness process or 
one which may initiate such a process. Training would look at what these are, for the 
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 patients, mapping these, making a list, raising an awareness of them, and keeping a 
diary. The carers in training will look at the awareness of these and develop an RPMC 
plan to minimise those risks and to develop confidence to avoid those situations. It is 
also an opportunity to continue with previous exploration to further identify the ‘Lapse 
and Relapse History’: What is the pattern of relapse from the past? Can we learn 
anything from that? Do we know why service users do not take their medication? With 
that knowledge, are there any actions or strategies that can be practised when next 
experienced that might reduce the risk of relapse? 
5. Identifying Warning Signs: What does the individual believe to be their earliest 
warning signs? These are not psychotic symptoms. These may include such things as 
withdrawal from help; a reluctance or refusal to take medication; a desire to take 
alcohol and/or drugs; sleeplessness, restlessness, increased agitation or irritability.  
6. Identifying Stress and Stress Management: How does the person with mental illness 
experience and cope when in stressful situations? Does this contribute to an increased 
risk of relapse? What effective (adaptive) coping strategies can be put in place when 
dealing with a stressful event? A plan is drawn up for dealing with stressful situations. 
For carers, the plan will also be about them and how they cope. 
7. Identifying Thinking Errors/Faulty Thoughts and management: There may be 
evidence that the patient has adopted what we call ‘thinking errors’, with statements 
such as ‘the medication you are giving me will poison my brain’. Collect a list of thinking 
errors and get service users to gather the evidence to support their thinking. Give them 
a thought diary that gets them to record what they thought and their resulting 
behaviour. Then one can introduce new possible ways of thinking about given 
situations. 
8. Identifying and Exploring Rule-violation Effect – Emotions and management: How 
does the person feel when they have not continued with a health plan, e.g. with their 
medication regime, for example? The rule-violation effect is about helping the service 
user look at their feelings, e.g. of guilt or blame when they have lapsed or relapsed in 
some way. It is also about having a plan to manage them, so that they are not distracted 
from further developing their relapse plan so that it is more successful. 
9. Identifying and Exploring Life Style Balance: This session is about teaching the 
service user to make choices that maintain a balanced life style. The notion of life style 
and its many components include: 
• Nutrition 
• Diet 
• Exercise 
• Friends 
• Family 
• Education 
• Recreation 
• Occupations 
• Holidays 
• Spiritual self 
• Accommodations 
• Finance 
• Partners 
It covers some of the practical things issues about ensuring that the client has some 
activity in each field, and is specifically aimed at educating the service user about choice 
and empowerment. Ultimately it forms the ‘global recovery and relapse prevention 
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 plan’ as a background to the ‘specific recovery and relapse prevention plan’ targeted on 
avoiding or coping with specific high-risk situations. 
10. Devising a Lapse and Relapse Plan: This session (sometimes two sessions) looks at 
problem solving techniques with the aim of teaching or reminding the service user or 
carer of problem solving. It pulls together all the information gathered in the previous 
sessions and draws up a plan for managing high-risk situations, such that the plans will 
reduce the risk of lapse or, if one occurs, the chance of continuation to the state of 
relapse. Each plan is very individual as relapse in each individual is triggered by different 
factors.  
11. Review/Evaluate Progress or Other: The final session is to review the work and how 
it has gone. 
Booster sessions may be needed if service users have a further need for training. This 
usually happens on reflection. The model proposed here provides a more 
comprehensive list of interventions for clinicians, service users and carers to work on, 
rather than a selective aspect of recovery and relapse prevention.  
Techniques commonly used in the Recovery and RP include: cognitive behavioural 
therapy; social learning theories; motivational interviewing techniques; family 
intervention; role play; visualisation; relaxation techniques; complementary therapy; 
solution focused therapy; harm minimisation and medication concordance; planning; 
network development; group therapy, etc.  
Therefore users, carers and healthcare workers would be working in partnership to 
discover how best to achieve individual goals with the ultimate aim of leaving the 
service user empowered. RP is a simple model to understand and to practice, but 
advanced competencies for users, carers and mental health workers are achievable on 
completion of advanced training in Recovery and RP.  
Instruments used in practice are: 
a. Attitudes of nurses 
b. Engagement measures 
c. Self-efficacy 
d. Empowerment 
e. Skills required for Recovery and RP. 
 
Rami Jumnoodoo 
Lead Nurses Relapse Prevention Project 
Reviewed May 2011 and 2013  
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 Appendix 3: Terms in MC 
The words compliance, adherence and concordance are used interchangeably in the 
context of prescribed psychiatric medicine-taking behaviour for those with Serious and 
Enduring Mental Illness (SEMI). The definitions and analysis of these terminologies are 
discussed fully in Appendix 1. Cameron in 1996 suggested there was no consensus on 
the determining criteria for non-compliance. This view is further supported by a report 
published by Horne and Weinman (1999) and Horne et al. (2005) for the National Co-
ordinating Centre for NHS Service Delivery and Organisation Research & Development 
(R & D) on Concordance, Adherence and Compliance in Medicine-taking (2005) 
(NCCSDO). Non-compliance is described as ‘sub-optimal adherence to treatment 
regimens’ (Kemp and David, 1995; Kemp et al., 1998) and ‘as active refusal or passive 
failure to adhere to the treatment regime as prescribed’ (MacPherson et al., 1997). The 
most popular definition is that of Haynes (1979: 174–90), who defines compliance as 
‘simply an extent to which the patient’s behaviour matches the prescriber’s 
recommendations’, which implies that there is little room for negotiation in order to get 
better.  
The Royal Pharmaceutical Society of Great Britain (RPSGB, 1997) has written a report in 
which it advocates a model of ‘concordance’ rather than compliance or adherence, but 
the fact that patients with SEMI continue to relapse suggests that there is a need to re-
examine all three definitions. 
Bell et al. (2007) conclude that concordance is not synonymous with compliance or 
adherence. Here the focus is based on the patient’s relationship with the clinicians and 
has nothing to do with whether the patient takes their medication or not (National 
Institute for Health and Clinical Excellence (NICE), 2009). Concordance does not refer to 
a patient's medicine-taking behaviour, but rather the nature of the interaction between 
clinicians and patients. This suggests patients have the freedom to either take risks of 
relapse or benefit from taking their prescribed medication; a view supported by 
Alaszewski (2005), who also purports equal partnership between clinicians and patients. 
NICE (2009) supports these arguments by recommending active involvement of patients 
in decisions about prescribed medicines and, in effect, endorsing the concept of 
concordance in practice. However, it must be said it is left to the clinicians to find 
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 suitable training and developing ways to tackle concordance of medication in practice. 
Currently the choices of existing interventions by nurses is difficult to identify as often 
these are mentioned in the literature but not described fully. This notion is central to 
this study.  
However, there is a gulf between these ideals and practice, as there are inherent 
complexities and partnership-related values (Cribbs, 2011). These may include the 
concept of concordance, which is often misunderstood (Clyde, 2005); nurses may 
believe they are practicing concordance when in reality they are not (Latter et al., 2007, 
2010) and concordance may not have a realistic impact in patients centredness (Gray, 
2010). 
There are further difficulties with decision making and autonomy. Patient’s values are 
not necessarily coherent (Cribbs, 2011) and it can become meaningless if they do not 
engage with nurses or clinicians; conversely they may engage in discussion options but 
not necessarily agree to decision making on taking their medication (De Las Quevas, 
2011). Therefore, recognising these issues makes the concept of concordance clearer in 
the clinicians’ minds in practice and makes it more plausible to enhance success. To 
enhance concordance, therefore, there is a need to share power and to value leaning 
towards the patient’s values, views, options, by sharing information including 
uncertainties that may require further assessment and treatment plan. In addition, 
there should be dedicated time and careful listening to the patients’ concerns (Degan, 
2004).  
In this assignment, the focus will be on medication concordance. This is to tackle the 
factors of medication non-concordance leading to relapse and to establish how a new 
teaching programme of RPMC can be of benefit to mental health nurses in their role of 
facilitating medication concordance. However, the words ‘concordance’, ‘adherence’ 
and ‘compliance’ will all be used as there is no agreement over preferred use in 
healthcare settings (Horne, 2005; NCCSDO (National Co-ordinating Centre for NHS 
Service Delivery and Organisation Research & Development (R & D) on Concordance, 
Adherence and Compliance in Medicine-taking).  
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 Appendix 4: Letters to Participants 
 
Dear Sir/Madam  
Re: Relapse Prevention: Relationship to Medication Concordance: A Programme of 
Staff Education 
Please read the following the information leaflet carefully. It describes what will happen 
to you if you decide to participate in the above study. We are attempting to investigate 
the effects of a two-day Relapse Prevention and Medication Concordance (RP/MC) 
teaching programme delivered to staff over two days. This will include changes in scale 
scores relating to: Skills, Self-efficacy and Attitudes of psychiatric nurses towards 
medication concordance.  
If you agree to take part in the study you may be asked to attend the Relapse 
Prevention programme held at Brondesbury Road, Training Room 12. 
We hope you will participate in the study as we believe that, if it is shown to be 
beneficial, the RP/MC programme will improve the care of Mental Health Service users 
in general.  
Yours sincerely 
 
Rami Jumnoodoo, Principal Researcher 
Relapse Prevention Office  
13-15 Brondesbury Road  
Kilburn, NW6 6BX 
 
Tel: 02089371641 
Mobile: 07958367753 
E-mail: rami.Jumnoodoo@nhs.net 
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 Appendix 5: Consent Form 
                                                  Rami Jumnoodoo, Principal 
Researcher 
Relapse Prevention Office 
13-15 Brondesbury Road 
Kilburn 
NW6 6BX 
Tel: 02089371641 
Mobile: 07958367753 
E-mail: rami.Jumnoodoo@nhs.net 
 
Name: 
Address: 
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 CONSENT FORM                            
Title: Relapse Prevention: Relationship to Medication Concordance: A Programme of 
Staff Education 
 
Name of Researcher:  Rami Jumnoodoo 
       Please initial boxes 
1. I confirm that I have read and understand the information sheet dated 8th April 
2012 for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my duty to care or legal rights being 
affected.  
3.  I understand that all the relevant data collected during the course of this 
research will be kept confidential on the computer which will be password protected 
and any transcriptions tapes etc will be secured in a locked drawer and in a locked 
room.  Only members of the research team will have access to those data.  
4.   I agree to take part in the above study.  
5.  Do you agree to be part of the focus group? 
    Yes                No 
Name of Participant…………………………………… Date………………….  
Signature…………………………. 
Name  of Assistant  Researcher ………………………Date…………………. 
Signature ………………………….. 
When completed, 1 (original) for researcher site file.    
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 Appendix 6: Participant Information Sheets 
 
Participant Information Sheet 
Relapse Prevention: 
 
Relationship to Medication Concordance - 
A Programme of Staff Education 
by Rami Jumnoodoo 
8th April 2012 
Rehabilitation Service Line Research Initiative – in partnership with Middlesex University 
Introduction 
 
You are being invited to take part in a research study. Before you decide on your 
participation, it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully and talk 
to others about the study if you wish. If there is anything that is not clear, or if you 
would like more information, please do not hesitate to ask questions. Take time to 
decide whether or not you wish to take part. 
Should you decide to take part, your line manager will be informed of your involvement 
in the study and that it will not affect your nursing activities in anyway.  
What is the purpose of the study? 
During the past thirty years a number of techniques that were originally applied to 
substance abusers have been transferred to the mental health field. One of these is 
Relapse Prevention with a focus upon encouraging medication compliance.  
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 The study involves a two-day group Relapse Prevention and Medication Concordance 
(RP/MC) teaching/training programme for staff, using a manual template designed by 
the current applicant. This face-to-face training will be delivered by an experienced 
trainer, i.e. the applicant, in two groups of 10 over two consecutive days, 10.00 am - 4 
pm. At the end of the programme there will be an evaluation questionnaire to assess 
whether the training has been absorbed and to measure changes in skills, self-efficacy 
and attitudes of psychiatric nurses towards medication concordance. This will be done 
by an independent researcher.  
This project forms part of a Master of Professional Studies (MProf) programme and is a 
student research project. The supervisor is Dr Kay Caldwell - Head of the Institute of 
Nursing and Midwifery at Middlesex University and the Clinical Supervisor is Dr John 
Foster, Principal Research Fellow - Department of Family Care and Mental Health at the 
University of Greenwich. 
Why have I been chosen? 
The reason you have been chosen is that the study focuses on qualified community or 
ward-based nurses, (Bands 5/6), employed by Central and North West London NHS 
Foundation Trust (CNWL) who have not received post-registration training in any of the 
following - motivational interviewing, cognitive behavioural therapy, relapse prevention 
and medication concordance. In total, 20-30 Community Psychiatric Nurses (CPNs) have 
been selected for this study and you are one of them.  
Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do, you will be given this 
information sheet to keep and you will be asked to sign a consent form. You are free to 
withdraw at any time and without giving a reason. A decision to withdraw at any time, 
or a decision not to take part, will not affect you in any way but it will count towards 
your professional development. 
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 What will happen to me if I take part?  
You will be asked at the initial stage to complete a socio-demographic questionnaire 
which will include age, gender, ethnicity, length of time in service, and previous training 
experience. Then you will be allocated to either Group 1 or 2. The names will be placed 
in an urn and initially 30 will be selected by an independent person. It is purely for 
convenience reason as the training room can only accommodate 12-14 people in 
comfort.  
At this initial stage you will also be invited to be part of a small focus group. There will 
be no pressure put on you if you do not wish to participate in the focus group.  
In addition each participant will be asked to complete three survey tools. 
1. General Self-efficacy Scale. This is a 10-item psychometric scale that is designed to 
assess self-beliefs to cope with a variety of difficult demands in life. It measures the 
belief that one's actions are responsible for successful outcomes.  
The questionnaire is short (10 items) and take 5 minutes to complete. It is 
recommended that you do not spend too much time on each individual statement.  
2. Attitudes towards patients who do not wish to take their medication. It consists of 
12 items each scored on a four point Likert scale and thus the range of scores is 12-36. 
An item score of 2-3 means that the participant agrees with the principle of 
concordance. The adaptations are to substitute the term nurse for doctor and service 
user to patient for that question. 
Permission for the use of the above questionnaires was obtained from the designers. 
3. Level of skills in using relapse prevention techniques with the aim of enhancing MC. 
On this occasion we will be designing a tool that specifically relates to the relapse 
prevention programme as no validated measure currently exists. This will be based on 
the topics covered and techniques used in RP/MC course. The researcher’s 
knowledge/experience/literature will be used to devise the questionnaire which will 
then be shown to other professional colleagues and service users/carers who will advise 
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 as to whether or not the tool is comprehensive enough and who may suggest other 
items that could be added. The questionnaire will then be piloted by participants who 
will not be in the final study. A modified Likert scale of 1- 5 will be used: 1 being Strongly 
Disagree, 5 being Strongly Agree and 3 being Neutral. The scoring will be used to 
analyse the total scores at Point 2 and 3 (see below), to find out whether there has been 
a change in attitude. 
You will be surveyed at three time points by an independent researcher who will not 
deliver the programme; 
• Baseline (Point 1) 
• One week following the end of a 10-session RP/MC programme (Point 2) 
• Three months following the end the programme (Point 3)  
10 weeks following the programme, the agreed participants in the focus group will be 
interviewed to explore the impact of the programme and gain further insight into the 
value of the programme delivered. This interval has been chosen as to have integrated 
this with the administration of the surveys would risk the participants being influenced by 
their answers.  
Description of the Programme 
RP/MC uses skills that help individuals to develop self-efficacy and maintain overall 
wellbeing in their own communities. RP skills training involves improving self-
management of illness-related problems in order to restore and enhance hope. Training 
staff in the following areas is expected to enhance their skills, to improve their attitude to 
medication concordance.  
The topics covered will be as follows: 
1. Engagement/Contracting 
2. Introduction to the RP model 
3. High-risk situations  
4. Learning the difference between Lapse and Relapse  
5. Early-warning signs and relapse signatures  
6. Managing stress  
7. Managing faulty thoughts 
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 8. Rule-violation effect 
9. Developing a balanced life style 
10. Learning problem solving (individual) 
11. Personal lapse and relapse plan 
12. Evaluation of progress 
13. Disengagement 
14. Reinforcement sessions if required. 
 
All the above items are issues that are linked to medication concordance. 
What are the other possible disadvantages and risks of taking part? 
This study is not invasive and the research team do not envisage any risks or 
disadvantages from taking part. During the RP/MC two-day training you need to make 
sure you feel comfortable about the sessions. If these sessions cause you to feel 
uncomfortable in any way (e.g. having to express yourself in front of others) then you 
should notify us immediately and you will be free to withdraw from the study without 
any consequences. You will be offered extra support if required.  
What are the possible benefits of taking part? 
We anticipate great benefits to participants receiving the RP/MC training in improving 
their self-efficacy, skills and knowledge and attitude to medication concordance which 
in turn will benefit their patients with medication compliance problems. If you are one 
of the participants of the focus group, the intention is to explore the concepts in greater 
depth and in this study we have chosen a focus group consisting of 6-8 participants. This 
study will provide data that will help participants to understand the best services to 
offer mental health service users. Some participants may wish to use the research 
outcome to further their own academic studies and test other aspects of RP and MC.  
What happens when the research study stops? 
Firstly, there would be an analysis of all quantitative and qualitative data collected from 
the questionnaires and also from the focus group interviews. The outcomes will form 
part of my Master of Professional Studies thesis which will no doubt provoke some 
critical discussion and also recommendations for the future direction of the project. A 
copy of the outcomes from this research will be made available for you to read. 
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 This study will in the first instance be published in the Health and Social Service Bulletin 
and the Trust In Brief newsletter and at Clinical Governance meetings to raise 
awareness locally and Trust wide. There is also the possibility of presenting this work 
nationally and internationally through conferences, workshops and entry to National 
Award competitions e.g., Health Service Journal and the Nursing Times. The aim is that 
the findings will be published in academic, clinical and practice-related journals such as 
the Mental Health Journal of Psychiatric or Mental Health Nursing or the British Medical 
Journal. 
Finally, you will be rewarded with a certificate of attendance and participation in this 
piece of research. 
What if there is a problem?  
If there are any problems you should approach the principal researcher, Rami 
Jumnoodoo (contact details at the end of this document) to provide you with support in 
the first instance. Furthermore, counselling and support will also be available to you 
during the RP/MC programme to deal with any administrative or personal issues you 
may have. 
Will my taking part in the study be kept confidential?  
Your personal details will be kept anonymous and instead, you will be allocated a 
number that will be known only to the research assistant who is entering the data. This 
is so that the research assistant can ensure that follow-up data relates to the correct 
individual. Thereafter all data will be recorded stored and analysed according to the 
requirements of the Data Protection Act 2003. Specifically all computerised data will be 
password protected and any transcription tapes etc. will be secured in a locked drawer. 
Finally, each participant will be informed that the focus group data will be reported so 
that anonymity is protected.  
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any time. You will not be disadvantaged in 
any way. 
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 What will happen to the results of the research study? 
This study is part of a professional Master’s qualification. It will be written up and 
submitted for assessment as part of that process. We also hope to publish the findings 
more widely in professional and academic journals. Should you wish to receive a 
summary of the research findings please contact Rami Jumnoodoo (0208-937-1641). 
Please be assured that the reports from the study will be written in such a manner so 
that you cannot be personally identified from them. 
Who is organising and funding the research?  
The research was organised by Middlesex University and funded by Brent Mental Health 
Services. Researchers, participating in this study, will not receive any additional funding 
as a result of the study. 
Who has reviewed the study?  
The Middlesex University Academic board and the Research and Development 
Committee/ Integrated Research Application System have reviewed this study 
independently. 
Do you have any questions? 
Remember, if you have any questions, to ask the researcher or the independent adviser: 
1. Rami Jumnoodoo, Principal Researcher 
Relapse Prevention Office 
13-15, Brondesbury Road 
Kilburn 
LONDON  NW6 6BX 
Tel: 020 8937 1641 
Mobile: 0795 836 7753 
E-mail: rami.Jumnoodoo@nhs.net 
2. Dr Kay Caldwell, Research Supervisor 
Head of Institute of Nursing and Midwifery 
Middlesex University 
The Archway Campus 
Highgate Hill 
LONDON   N19 5 LW 
Tel: 020 8411 6458 
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 E-mail: K.Caldwell@mdx.ac.uk  
 
3. Dr Patrick Coyne (Independent Adviser) 
Lead for Education  
Westminster Sector Manager 
Latimer House 
40-48 Hanson Street 
LONDON   W1W 6UL 
Tel:020 7612 1620 
Mobile: 0783 788 5178 
E-mail: patrick.coyne@nhs.net 
 
Thank you for reading this information sheet.  
Please keep it in a safe place.  
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 Appendix 7: R & D Approval 12, MHS 16 
 
North Central London Research Consortium 
3rd Floor, Bedford House 
125 - 133 Camden High Street 
LONDON  NW1 7JR 
North Central London Research Consortium 
18/07/2012 
 
Mr Rami Jumnoodoo 
Relapse Prevention Unit 
12-15 Brondesbury Road 
Kilburn 
LONDON  NW6 6BX 
 
Dear Mr Jumnoodoo, 
I am pleased to confirm that the following study has now received R & D approval, and 
you may now start your research in the Trust(s) identified below. (Trust name deleted) 
Study Title: Relapse Prevention: Relationship to Medication concordance- A 
programme of Staff Education 
12MHS16 
N/A 
R&D reference: 
REC reference: 
 
If any information on this document is altered after the date of issue, this document will 
be deemed INVALID. 
 
Please ensure that all members of the research team are aware of their responsibilities 
as researchers which are stated in page 2. For more details on these responsibilities, 
please check the R & D Handbook or NoCloR website: http://www.noclor.nhs.uk 
We would like to wish you every success with your project. 
Yours sincerely, 
 
Mabel Saili 
Senior Research Governance Officer 
R&D approval 18f7!2012 R&D reference 12MHS16 Page 1 of 2 
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 Appendix 8: General Self-efficacy Questionnaire 
This self-efficacy measure was chosen because it has established psychometric 
properties developed and used use in 10 cultures (Schwarzer, 1993). The General Self-
efficacy Scale is a 10-item psychometric scale to assess optimistic self-beliefs to cope 
with a variety of difficult demands in life. It measures the belief that one's actions are 
responsible for successful outcomes. The questionnaire is short (10 items) and take five 
minutes to complete. It is recommended not spend too much time on each individual 
statement. The participants were asked to provide the level of agreement with each of 
the statements below, by circling their response, using the scale provided. 
The questionnaire should not take long to complete. Please do not spend too much time on 
each individual statement. Answer the statement in accordance to how you feel in the here 
and now.  
  Never Perhaps Occasionally Always 
1. I can always manage to solve difficult problems if I try hard enough 1 2 3 4 
 
2. 
If someone opposes me, I can find 
means and ways to get what I want 1 2 3 4 
3. It is easy for me to stick to my aims and accomplish my goals 1 2 3 4 
4. I am confident that I could deal efficiently with unexpected events 1 2 3 4 
5. Thanks to my resourcefulness, I know how to handle unforeseen situations 1 2 3 4 
6. I can solve most problems if I invest the necessary effort 1 2 3 4 
7. 
I can remain calm when facing 
difficulties because I can rely on my 
coping abilities 
1 2 3 4 
8. When I am confronted with a problem, I can usually find several solutions 1 2 3 4 
9. If I am in trouble, I can usually think of something to do. 1 2 3 4 
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Thank you for your time and effort to participate within this research. 
(This questionnaire was adapted from Ralf Schwarzer’s research on General Perceived 
Self-efficacy in 14 Cultures (1993). 
Schwarzer R (1993) Measurement of Perceived Self-efficacy. Psychometric scales for 
cross-cultural research. Berlin: Freie Universität. 
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 Appendix 9: Leeds Attitudes towards Concordance Scale 
The Leeds Attitude towards Concordance scale (LATCon) (Thistlethwaite et al., 2003) is a 
validated measure and consists of 12 items each scored on a four point Likert scale and 
thus the range of scores is 12-36. An item score of 2-3 means that the participant agrees 
with the principle of concordance. There is a small adaptation adaptations are to 
substitute the term nurse for doctor and service user to patient for that question. 
The participants were asked to provide the level of agreement with each of the 
statements below, by circling their responses, using the scale provided. 
 
 Strongly disagree Disagree 
Neither agree 
or disagree Agree 
Strongly 
agree 
1. 
Nurse-service user 
consultations should be 
viewed as negotiations 
between equals. 
1 2 3 4 5 
2. Nurses should respect service user’s personal beliefs. 1 2 3 4 5 
3. 
The best use of medicine is 
when it is what the service 
user wants and when it is likely 
to achieve the desired results. 
1 2 3 4 5 
4. 
Dispensing medication can be 
viewed as an experiment 
carried out by service user 
under the guidance of the 
prescribing doctor just as 
taking medication is an 
experiment carried out by 
patients. 
1 2 3 4 5 
5. 
Nurses should allow service 
user to discuss their thoughts 
and feelings about their illness 
and how it should be treated. 
1 2 3 4 5 
6. 
Improved health would result 
from co-operation and mutual 
respect between service user 
and patients. 
1 2 3 4 5 
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 Strongly disagree Disagree 
Neither agree 
or disagree Agree 
Strongly 
agree 
7. 
It is important that nurses and 
service user establish an 
agreement about the need for 
medication. 
1 2 3 4 5 
8. 
Nurses should take account of 
service user’s needs, desires 
and abilities when discussing 
medication. 
1 2 3 4 5 
9. 
Nurses should try to help 
service user’s make as 
informed a choice as possible 
about the benefits and risks of 
alternative treatments. 
1 2 3 4 5 
1
0. 
The most important decision 
during the nurse-service user’s 
consultation is that of the 
patient. 
1 2 3 4 5 
1
1. 
Nurses should be more 
sensitive to the reactions of 
service user towards 
information they are given 
regarding their treatment. 
1 2 3 4 5 
1
2. 
Nurses should learn about the 
beliefs held by service user 
about their medication 
1 2 3 4 5 
 
Thank you for your time and participation 
Thistlewaite J E, Raynor D K, and Knapp P (2003) Medical students’ attitudes towards 
concordance in medicine taking: Exploring the impact of an educational programme. 
Education for Health. 16(3)307–17. 
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 Appendix 10: Approval for Use of Questionnaires 
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 Appendix 11: Skills Capability Questionnaire 
 
Maintaining Medication Concordance 
Using Relapse Prevention Skills 
Skills Capability Questionnaire 
 
On this occasion the above tool was designed to relate specifically to the relapse 
prevention programme, as there was currently no validated measure. This was based on 
the topics covered and techniques used in RP/MC course. The author’s 
knowledge/experience/ literature were used to devise the questionnaire, which was then 
shown to other professional colleagues and service users/carers who advised as to 
whether or not the tool was comprehensive and made suggestions for additional items. 
Changes were made to ensure the questionnaire reflected the contents of the course. 
Then it was piloted by participants who were not to be part of the final study. Only one 
minor suggestion was made. It was felt that it ought to be more user friendly. This was 
achieved presenting it more elaborately, without any alteration of its contents. At 
that point, the questionnaire was ready for use.  
A modified Likert scale of 1–5 was used, 1 being Strongly disagree, 5 being Strongly 
agree and 3 being Neutral. A mean item score of 2–3 means that the participant tended 
to agree with the concept of concordance whilst an average score of lower than 2 
suggested he/she did not.  
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Strongly 
disagree Disagree 
Neither 
agree or 
disagree 
Agree Strongly agree 
1. I have the skills to engage with service users in Medication Concordance 
 
1 
 
2 
 
3 
 
4 
 
5 
2. 
I have the skills to convey information 
about Medication Concordance to 
service users. 
 
1 
 
2 
 
3 
 
4 
 
5 
3. 
I have the skills to motivationally 
interview service users to promote 
medication concordance 
 
1 
 
2 
 
3 
 
4 
 
5 
4.  I have the skills to engage service users in Relapse Prevention planning 
 
1 
 
2 
 
3 
 
4 
 
5 
5. 
I have the skills to select appropriate 
techniques to promote Medication 
Concordance with service users 
 
1 
 
2 
 
3 
 
4 
 
5 
6. 
 
I have the skills to select appropriate 
techniques to Relapse Prevention plan 
with service users 
 
1 
 
2 
 
3 
 
4 
 
5 
7 
I have skills to identify the causes (high 
risk situations) of non concordance of 
medication with service users 
 
1 
 
2 
 
3 
 
4 
 
5 
8 
I have the skills to plan with service 
users to improve their medication 
concordance 
 
1 
 
2 
 
3 
 
4 
 
5 
9 
I have the skills to enables service users 
to identify their early warning signs of 
non-concordance with their medication 
plan.  
 
1 
 
2 
 
3 
 
4 
 
5 
10. 
I have the skills to explore and manage 
stress, faulty thinking and rule violation 
with service users as part of relapse 
prevention planning. 
 
1 
 
2 
 
3 
 
4 
 
5 
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 Please indicate your level of agreement with each of the statements 
below, by circling your response, using the scale provided 
 
 
Thank you for your time and participation 
 
Jumnoodoo, R (2011) 
 
 
 
  
11. 
I have the skills to develop lifestyle 
balance with service users as part of 
relapse prevention planning to support 
their plan for medication concordance. 
 
1 
 
2 
 
3 
 
4 
 
5 
12 I have the skills to help service users plan a medication concordance plan. 
 
1 
 
2 
 
3 
 
4 
 
5 
13. 
I have the skills to plans with service 
users a Relapse Prevention plan to 
ensure the implementation of their 
medication concordance plan. 
 
1 
 
2 
 
3 
 
4 
 
5 
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 Appendix 12: Wilcoxon test, P-value, Means, Medians, SDs 
Wilcoxon Signed Rank Test, P values, mean, median ranges and Standard Deviation 
(SD) 
The Wilcoxon Signed Rank Test was chosen because of the abnormal data distribution 
and the small sample size, which required non-parametric testing. The Wilcoxon test 
was used for within-group analysis because in this study there is repeated 
measurements on a single sample to assess whether their population mean rank differs 
between the pre-, the post- and the follow-up sessions. It will also provide the median 
and range for comparisons along with the P-value. 
The P-value is often fixed at 0.05 and serves against the test generated P-value, which 
must be either higher or lower than 0.05. Therefore the P-value is significant to 
determine whether to accept or reject the null hypothesis: in other words, there is no 
significant difference in the measured outcomes.  
If the P-value associated with the test statistic is less than P-value=0.05, the null 
hypothesis is rejected because there is a statistically significant difference between the 
two groups. Conversely, if the P-value is greater than P=0.05, then the null hypothesis is 
accepted because there is no statistically significant difference between the groups. In 
order to either accept or reject the study findings, other metrics based on the P-value 
should be considered. The mean, Standard Deviations (SDs), median, ranges and P-
values will all be reported. The median is the number that occurs in the middle of an 
ordered sequence of scores. The range is a measure of how spread the scores are (i.e. 
minimum and maximum values). SDs measure the spread of individual results around 
the mean of all results. This is used, together with the median, in describing either a 
normal or abnormal distribution of data (skewed data), where the scores could be 
either high or low. The P-value is a summary of what the data said about the credibility 
of the null hypothesis. 
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 Appendix 13: Initial Themes from Steering Group 
We envisaged these will include:  
• Changes made in clinical practice since the RPMC course  
• Problems encountered when attempting to put enhanced knowledge and 
skills into practice  
• Any new skills gained during the 10 weeks since the RPMC course  
• Any adaptations made of the use of relapse prevention techniques, etc, in 
practice settings  
• Changes in attitude towards SUs with MC since completing the RPMC course 
• How attending this course may have enhanced personal or professional 
career development.  
Prior to the focus group, the themes were shown to nurses who have had accredited 
academic training in some form of psychosocial intervention for comment on whether 
the themes were comprehensive. A similar procedure was followed with selected 
service users/carers who had attended the RP course earlier. Following feedback from 
these two forums, the themes were amended and finalised. These amendments include 
that the fonts were too small, the word ‘clinical’ should be deleted and to use the word 
‘problem’ instead of the word ‘barrier’. Those comments were acted upon and 
amendments were made to finalise the questions, ready for use by the focus group 
(Appendix 15). A closed-ended question to each open-ended question, with a ‘yes’ or 
‘no’ answer, was also included to enable an aggregate data quickly. In this way, the 
respondent may want to justify their answer and thus add richness to both the 
qualitative and the quantitative data (Boynton, 2004). 
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 Appendix 14: Development of the Interview Guide  
An interview guide was developed to explore the impact of the RPMC programme and 
gain further insight into the value of the delivered programme. The interview guide was 
a necessary component in conducting the interviews. The idea was to obtain a personal 
story behind participant experiences (McNamara, 1999), where the interviewer will 
work directly with the interviewee, in comparison to merely administering semi-
structured questionnaires. Another aspect of using this method was that the 
interviewees provided valid responses to the impact of RPMC, rather than just a 
conversational approach, whilst allowing some flexibility and adaptability in extracting 
the required information from them. However, motivating the respondents to give 
precise replies may not be necessary in all cases as this depended on individual interest 
in the subject (Hoyle et al., 2002: 144). Another negative side of interviews is that they 
are time consuming in terms of setting up, interviewing, transcribing, analysing, 
feedback and reporting (Gillham, 2000: 9) and the interviewer has to be well trained to 
be able to respond to any contingency (Hoyle et al., 2002: 145). 
Rami Jumnoodoo 
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 Appendix 15: Interview Guide Finalised 
14/06/2013 
 
Key 
In Italic – instructions to the interviewer 
In black – information relayed to participants 
 
Re: Relapse Prevention: Relationship to Medication Concordance: A Programme of Staff 
Education 
The participant would have been briefed by the investigator and consent obtained at 
this point by the principal investigator. The following is intended to be used by the 
research assistant when collecting interview recording from participants.  
WARM UP 
My name is Nisha Parmar and I currently work the Trust as an Administrator/ Organiser. 
Although I work for the Trust I am only here to collect information that will remain 
confidential. Although the information will be used as part of a research project nobody 
will know who has provided the information, as names will be kept anonymous. I will 
give you an outline of the process and then I will ask you if you are happy to continue.  
The focus groups (research participants) will be delivered by two independent 
researchers, (Nisha and Albert) Albert who will facilitate the discussion and Nisha who 
will take notes regarding group interactions etc. The aim will be for the focus group 
participants to be representative in terms of gender, age, ethnicity, grade and type of 
professional experience. The proceedings will be recorded and thereafter transcribed. 
  
INTERVIEW SCHEDULE 
109 
 Brief view of what the interview involves: 
Today I will be asking you questions for you to answer and I will be here to clarify any 
questions to support you with answering the questions. These will be about:  
What changes (if any) have you made in your practice? 
What barriers have you encountered when attempting to put your enhanced 
knowledge into practice? 
Can you describe any new skills gained during the last 10 weeks? 
What adaptations have you had to make to use relapse prevention techniques etc. in 
a practice setting? 
Can you describe how attending this course may enhance your career development? 
Take your time answering the questions  
This is not a test. If you are not able to answer any questions please feel comfortable 
enough to move onto the next one. I will also be here if you need me to clarify any of 
the questions. Give clarification without leading the user to a particular answer. 
If you want to stop the interview for any reason then let me know - that is not a 
problem at all and will not affect you in any way whatsoever. It is important that you 
feel happy with the whole process. 
As I explained before although the information will be used in a research project, only 
the researchers will see this and no other individuals particularly those who are involved 
in your care will see individual responses. I will not be attaching your name to the 
questionnaires. Instead I will put down a number that is an individual code. This number 
will be used in place of your name, which will help me, identify for data analysis 
purposes – No one else will be able to know who completed the questionnaire. Are you 
happy that your information will be kept confidential? Do you have any questions on 
how it is kept confidential or what we do with the information? 
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 Are you happy for us to continue? 
If the participant is happy to do so, please present the first questionnaire 
Remember, this is not a test. I am only interested in what you feel, so there are no right 
or wrong answer. 
Do you have any questions before we begin? 
COOL DOWN and ASSURANCES 
I would like to thank you for taking the time to help us with this. Again I would like to 
assure you that your answers will not be used in any other way but for research 
purposes. Nobody will be provided with your individual answers. I have shown you how I 
record a number at the top of each questionnaire – This will ensure that your answers 
cannot be identified and your questionnaire will remain anonymous. 
The information you have provided will be of great importance to us and once the study 
is completed you will have a chance to see the outcomes of the entire research study. Do 
you have any questions? If you have further questions that you think of after today 
please refer to the information sheet that you were provided with where you will find a 
contact number. Please remember you can only answer questions that are related to 
today’s process and not any clinical questions you may have as I am not part of the team 
that provides you with support around your care.  
Thank you again and I wish you all the best 
Ensure that the coding is consistent and that the following demographic information is 
collected.  
If the research participant has asked you any questions during the process please ensure 
that you have recorded this down along with your answer – Please inform them that you 
will be doing this.  
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 Appendix 16: Routine RPMC evaluation questions 
Relapse Prevention/Medication Concordance Training Evaluation Form 
To help us improve the quality of our training, we would appreciate your feedback. 
Please indicate your response to the questions below by circling the appropriate 
number,  
With 1 = Strongly Disagree and 5 = Strongly Agree 
1. a) Was your interest sustained throughout the training 1 □ 2□  3□  4□ 5 □ 
2. Do you have a better understanding of:- 
a) Engagement……..................................                1 □ 2□  3□  4□ 5 □ 
b) The relapse prevention model ......................    1 □ 2□  3□  4□ 5 □ 
c) High-risk situations..........................................   1 □ 2□  3□  4□ 5 □ 
d) The difference between lapse and relapse......   1 □ 2□  3□  4□ 5 □ 
e) Early-warning signs and relapse signatures……  1 □ 2□  3□  4□ 5 □ 
f) Managing Stress……………………………….............    1 □ 2□  3□  4□ 5 □ 
g) Managing faulty thoughts…………………………….    1 □ 2□  3□  4□ 5 □ 
h) Rule-violation effect……………………………. ……….  1 □ 2□  3□  4□ 5 □ 
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 i) Developing a balanced lifestyle……………………….  1 □ 2□  3□  4□ 5 □ 
j) Problem solving………………………………………………  1 □ 2□  3□  4□ 5 □ 
k) Medication concordance…………………………………  1 □ 2□  3□  4□ 5 □ 
3. Did the course give you ideas about how to: 
a) Assess medication non-concordance  
1 □ 2□  3□  4□   5 □ 
b) Apply relapse prevention techniques in medication non-concordance  
1 □ 2□  3□  4□   5 □ 
c) Measure the relapse prevention/medication concordance   effectiveness. 
1 □ 2□  3□  4□   5 □ 
4. Overall, how would you rate the course? 
1 □ 2□  3□  4□   5 □ 
5. Would you recommend this course to others?  
            1 □ 2□  3□  4□   5 □ 
6. Would you recommend this trainer to others?  
       1 □  2□  3 □  4□   5 □ 
7. What did you like most about the course? 
…………………………………………………………………………………………… 
…………………………………………………………………………………………….  
113 
 8. Is there anything you would change to improve the course? 
……………………………………………………………………………………………. 
…………………………………………………………………………………………… 
9. Now that you have completed the course what additional training if any would be 
helpful? 
……………………………………………………………………………………………. 
……………………………………………………………………………………………. 
10. Other comments, observations or suggestions 
…………………………………………………………………………………………….. 
…………………………………………………………………………………………….. 
 
                         
                             
Thank you for your feedback! 
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 Appendix 17: RPMC Interview Guide (Semi-structured Questionnaire)  
1. Following the RPMC   course have changes occurred to improve your practice 
 Yes       □   No    □ 
    If yes please refer 1.1  
 
1.1. Can you describe what changes have taken place in your practice?  
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………… 
2. Have you encountered any barriers to implementing your learning from the course?   
Yes                                 No    □ 
If yes please refer 2.1  
 
2.1. What barriers have been encountered when attempting to put enhance RPMC knowledge 
into practice? 
………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………
…………… 
3. Following the RPMC course did you acquire any new stills to promote medication 
concordance?   
Yes        □No    □ 
If yes please refer 3.1  
 
3.1. Describe any new skills gained during the previous three months? 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………… 
4. Have you made any adaptations to your previous approaches to medication concordance?   
    Yes         □                        No    □ 
If yes please refer 4.1  
 
4.1. What adaptations have you made of the use RPMC techniques in your practice setting?  
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………… 
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 5. Has your attitude towards services users with medication concordance changed since you 
commence the medication concordance course?   
    Yes           □                     No    □ 
If yes please refer 5.1  
 
5.1 Can you describe the changes in your attitudes following participation in the course? 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………… 
6.  Do you think participation in the course will have had an effect on your career 
development?   
   Yes          □                      No    □ 
If yes please refer 6.1  
 
6.1 How has you career development been improved as a consequence of   attending this 
course? 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………… 
6.2. Think back a little. Do you think your initial score was accurate in comparison to that after 
the course? 
……………………………………………………………………………………………………………………………………………………
……… 
6.3 Any further comments you may wish to add 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………… 
 
 
Thank you for your participation! 
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 Appendix 18: Thematic Analysis Transcripts 
Q1. Following the RPMC course, have changes occurred to improve your practice?   
Interviewees: All 5 participants responded ‘Yes’.  
Level 1 Interpretation 
                          They all think that something has changed in their practice 
 
Q1.1: Can you describe what changes have taken place in your practice since the 
medication concordance course? 
Q1.1              Reflective Quotes Level 1 Interpretation 
 
E9 
I now have a better understanding of what 
medication concordance is about. I am also 
more aware of the problems with MC and now I 
am able to develop my skills with service users 
whilst giving information about their 
medications.  
1. Believed there is clarity 
about MC.  
2. Detect problems and 
solutions to MC. 
 
 
 
 
 
E39 
I’m dealing with quite a lot of clients in the 
community with complex cases more skilfully 
and offer more alternative choices if possible to 
improve medication concordance.  
I read more on RPMC now to increase my 
knowledge and skills to become more 
resourceful in dealing with complex issues such 
conflicts between using drugs and alcohol 
instead of their prescribed medication.  
As part of my work, practising RP on a 
continuing basis has helped me to reflect and to 
1. Too many difficult cases 
to manage 
2. Able to provide clients 
with choices to get better 
MC outcomes. 
3. Able to self-teach RPMC 
and independently solve 
difficult issues. 
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 develop more skills in terms of medication 
concordance.  
We need to offer other medication alternatively 
when it’s possible, what I mean is to review 
their medication and change them if needed. I 
am not a prescriber at the end of the day. 
4. Able to think back and 
make more progress in 
MC. 
5. To assess and review 
medication as required 
6. It is not my 
responsibility at the end of 
the day. 
 
 
 
 
 
E21 
 
 
 
I think it has improved my practice in the way 
I’m dealing with clients, who doesn’t want to 
continue with their medication, because initially 
if someone said to me ‘I don’t want to take my 
medication because its giving me side-effects’, I 
need to convince and to negotiate with them to 
take their medication. Since we went for this 
training I am more aware that we need to 
engage in a very therapeutic way with the client 
to know their views because they’re the one in 
this position and they know how they feel about 
it, they know this medication in and out even 
though we are the ones giving it to them but 
they are the ones experiencing it. I am able now 
to see from their own perspective not from my 
own one, as a clinician wanting them to be on 
this medication and thinking it’s good for you, 
best for you, so I do listen to them now when 
they say they don’t want to take it and 
sometimes some of them will say ‘OK, I just 
want to go without it for a couple of months 
and see how I will be able to manage and if 
 1. Believe in finding a 
better approach to clients 
with a negative view of 
taking medication. 
2. Foster better discussions 
with them to agree to take 
their medication, without 
being pushy. 
3. Since training recognises 
the need to have better 
relationships with patients 
to understand their 
thinking and feelings about 
not wanting to take 
medication (behaviour). 
4. They are the one with 
experience regarding their 
medication. 
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 things go wrong I will come back to you’, now I 
do really tend to listen to what they have to say 
and just say OK if you don’t want it now, just let 
us know, so that now I tend to work more with 
their carers or whoever is around them, now I 
am very sensitive to that. 
5. Paying more attention 
to the patient’s views as 
well as telling them the 
benefits of taking their 
medication. 
6. Keep an open door for 
them in case they want 
treatment after a trial 
period without it. 
7. Turn to carer or 
whoever is identified for 
help to assess patient if 
he/she is not engaging in 
MC. 
 
E20 
 
 
 
 
 
Well it has actually changed my practice 
following the course. I was approached in 
November/ December time by my manager, 
Nurse Lead, to introduce a medication 
concordance clinic, so that’s something that 
started at the beginning of December and she 
specifically approached me because I’d done the 
course and this was very useful to implement in 
to day-to-day practice. we booked patients in 
for a chat about their medication, what their 
expectations were in terms of therapeutic 
benefits of medication also any side-effects or 
problems, etc. All the time we are learning new 
tricks to negotiate with them about whether 
they believe the medication they are taking is 
good or bad for them and we want to know 
1. Recognition by manager 
to introduce MC Clinic to 
the service after the RPMC 
course. 
2. Patients talked about 
what they want to know—
pros and cons of 
medication. 
3. Discover new ways to 
come and get them 
involved in discussions, to 
understand their views, 
feelings and their beliefs 
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 what they are thinking so that we can share our 
opinions and views in a respectful way.  
 Why they are taking medication and any other 
questions, how they should take it and just to 
give them a bit more reassurance, a bit more 
autonomy and choice over their medication as 
well. We’ve had someone to come over to try 
and do an audit on the benefits of it, can’t 
remember the name of the audit but it’s an 
audit about quality control within our team, so 
we met  my manager and other colleagues there 
has been a lot of changes and I think it was 
triggered by my attending the course. 
about the good and bad 
effects of medication. 
4. Felt she was 
instrumental in raising the 
profile of the service 
through a positive quality 
standard monitor. 
5. Recognised the training 
was the instrument for 
such a change. 
 
 
 
E22 
 
I can now offer better explanation and 
education to service users regarding positive 
and negative aspects of medication and 
treatment programme re concordance.  
Service users are in a better position to evaluate 
their progress, ability to recognise early-warning 
signs and relapse signature.  
It also improved service users’ ability to 
recognise their strengths and weaknesses.  
 
1. Feel at ease in getting the 
information and knowledge 
across on positive and 
negative aspects of 
medication with confidence. 
2. Service users are 
developing their assessment 
skills for their symptoms of 
relapse. 
3. Service users are 
becoming more aware of 
their strengths and 
weaknesses regarding their 
medication. 
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 Level 2 Summary Interpretation of Q1 
       Level 2: Summary Interpretation of QI by the Focus  Group 
The beliefs among participants are reported to be clearer for the understanding, 
assessing, planning and monitoring of an MC plan. This is achieved through 
confidence in fostering better relationships with patients and being able to negotiate 
skilfully with the patients in order for them to continue to take their medication. 
Should they decide not to do so, then alternative options are left open for them to 
choose from, including getting back into the treatment service as soon as they feel 
the need according to their self-assessment of their lapse or relapse symptoms, i.e. 
EWS. In practice, the nurses involved in the focus group are seemingly able to 
investigate the thinking, feelings and approach of patients regarding their medication. 
In so doing they are now becoming to some extent more familiar with the cognitive 
behavioural theory fundamental to the relapse prevention model, which is the basis 
of RPMC. Whilst the relationships between the nurses and patients are becoming 
transparent, one participant has been instrumental in introducing the first MC clinic 
in her service.  She is proud to be recognised for her success and innovation in 
bringing prestige and quality to the service. 
 
Thematic Analysis of Interview Transcripts 
Q2. Have you encountered any barriers to implementing what you have learnt from the 
course? 
Interviewees: All 5 participants responded ‘Yes’.  
Level 1 Interpretation 
                 They all think that there are problems in applying RPMC to their practice. 
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 Q2.1: What barriers have been encountered when attempting to put 
enhanced RPMC knowledge into practice? 
 
Q2.1              Reflective Quotes Level 1 Interpretation 
 
 
 
 
 
E9 
Yes there are various, significant increases in our 
workload. Asking the right question. How to answer 
the question. It is difficult to put Relapse and 
Prevention strategy techniques for all of them when 
you do the following-up process over medication 
concordance, it’s a skill you promote, when people 
are not well and when they stop taking their 
medication. 
Our own beliefs as nurses who spend more time 
with the patients, [we] think we know best of how 
to deal with patients who are not taking their 
medication but with a reality check we have got a 
long way to go to be competent in medication 
concordance.  
We need updates, supervision and time to reflect 
on where we go wrong and lessons to learn from 
our colleagues when they get things right. 
Medication to prevent relapse, many clients have 
got high risk and could not remember all of them so 
it’s difficult to implement RPMC strategies. 
 
 
1. Too many things to do 
2. Only some patients get 
the RPMC benefits in the 
after care. When they are 
not well and not taking their 
medication concordance 
needs to become more 
focused.  
3. Nurses can be inaccurate 
in their perception in that 
they believe they know 
more about MC when in the 
‘real world’ there is a lot for 
them to learn in the future. 
4. There doesn’t seem to be 
proper supervision and 
team learning of MC. 
5. Self assessment by 
patients can be problematic 
for nurses to implement an 
MC plan. 
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E39 
The course itself is not the barrier but it is difficult 
to keep track on all patients as they are discharged 
as soon as they are well and new ones come in and 
therefore difficult to monitor them. 
I am not prescriber and need to consult Drs for 
medication changes. 
If patient is well for few months, then he/she can 
relapse if there are changes in medication so there 
is fear to relapse if medication changed.  
Unfortunately I can’t remember all the clients; yeah 
basically what I do is a triage, where the clients are 
assessed and referred to the appropriate service. 
1. It is difficult to know what 
is going on with the patients 
once discharged from the 
service as they are 
constantly being replaced by 
new ones. 
2. It is not in nurses’ power 
to prescribe medication. 
3. Patients are afraid of 
relapse due to changes to 
medication which had 
previously kept them well 
over the last few months. 
4. Not really following or 
treating patients in their 
new role. 
 
 
 
 
 
E21 
 
 
Difficult to work with patient who is adamant not to 
take their medication because of their culture and 
religion.  
What they are saying is something to do with their 
culture, some time Muslim service users says they 
will read Quran and it will help them to calm down.  
Difficulty will also arise when it comes to put MC in 
practice after learning such a lot on the course. 
There is not enough time during the day to fully 
implement, monitor and to review the effects of 
1. Patients’ strong beliefs 
because of their culture can 
affect their MC as they may 
have a fierce resistance to 
take medication, e.g. Muslim 
SUs rely on reading the 
Quran to improve their 
mental health. 
2. Too much information 
from the course can actually 
create problems for 
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  their medication and we feel bad about it all the 
times. 
I can recognise their cultural background and their 
beliefs. The course has helped me to understand 
them better way now. 
implementing MC on the 
whole. 
3. Not enough time to 
complete a MC process and 
there is an associated guilt 
feeling about this. 
4. RPMC course has helped 
participant to a greater 
understanding about 
patients’ beliefs and culture. 
 
 
 
E20 
 
 
 
Given example of depot injection; No matter how 
we work, there are a few clients who do not want 
to take medication.  
Difficult to offer RP techniques to every patient 
especially when they are well or not taking their 
medication.  
Guess we all have a bit of nerves when putting 
things in practice and RPMC without supervision 
makes it difficult for us to apply.  
It’s quite a difficult question seeing as it’s been so 
long I can’t quite remember, some of the stuff that 
we did learn, I think probably because I work in a 
more of a primary care setting rather than 
secondary care, some of the medication compliance 
and concordance issues, so it’s something good to 
know. I know there are many barriers especially an 
1.  Having a depot injection 
instead of having to take 
medication every day is useful 
if patients explicitly refuse to 
take their medication. 
2.  Patients when well do not 
feel the need to take 
medication and therefore it is 
difficult to apply an RPMC 
plan. 
3.  Putting RPMC in practice 
without supervision can be 
stressful for some nurses to 
apply. 
4.  Having learnt so much from 
the course it is difficult to use 
RPMC in the participants’ 
current role but they can see 
the benefit of the lesson learnt 
and they also recognise 
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 increased caseload and large volume of paperwork 
and documentation.  
nurses’ heavy caseload and 
administrative duties can 
impact on working with RPMC.  
 
 
 
E22 
 
I do not have sufficient time to fully implement, 
monitor and review medication concordance 
approach due to large caseload.  
There is also an increase volume of documentation.  
There is also a lack of appropriate levels of support 
to staff to educate service users in medication 
concordance. 
 1. Too busy to implement 
MC properly due to too 
many cases and paperwork 
2. Not enough support from 
line managers to recognise 
the importance of sharing 
knowledge with patients 
about MC. 
 
Level 2 Summary Interpretation of Q2.1 
        Level 2: Summary Interpretation of Q2.1 by the Focus Group 
 It is clear from patients’ views about taking medication that the burden on nurses to 
implement MC is difficult, in practice. Although nurses have good intentions to use 
RPMC, the volume of increased caseload and paperwork seems to be the main barrier 
to implementing it and this is compounded by lack of support, supervision and 
updates or too much information from the course, which they do not have the 
confidence to apply in practice. Adding to these variables, some patients’ recovery is 
hindered by not taking their medication until they recognise they are unwell. Instead 
beliefs and culture are often used as an alternative to medical treatment and they 
fear relapse when changing to a new medication regime. Although nurses can see the 
benefits of the course, they are not able to practise MC in situations where patients 
have been discharged from their care.  
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 Thematic Analysis of Interview Transcripts 
Q3: Following the RPMC course did you acquire any new skills to promote medication 
concordance? 
Interviewees: All 5 participants responded ‘Yes’.  
Level 1 Interpretation 
                          They all think that something has changed in their practice. 
 
Q3.1: Describe any new skills gained during the past six weeks? 
Q3.1                  Reflective Quotes Level 1 Interpretation 
 
E9 
Developing strategies, it has provided me with 
broader knowledge, I have been implementing 
strategies with clients who don’t want to take 
their medication, making them aware of 
medication. 
I feel a bit better about solving problems after 
the course and now after six weeks or so, I feel I 
am getting there but not all there yet. We are 
becoming more like medication detectives in 
working with their faulty thinking such as the 
tablets they are being given are poisoning their 
brains and body and they are here only for the 
good of the doctor who gets lots of money from 
the drug companies and they do not care about 
them really. 
1.  Developing more 
knowledge of RPMC to 
implement it in practice 
2. Satisfied in improving 
problem-solving skills 
regarding issues relating to 
RPMC. 
3. Better skills assessment 
in dealing with RPMC 
concepts such as negative 
perceptions of patients’ 
medication, which could 
lead to them leaving their 
support service. 
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E39 
I have a better understanding of SUs’ capacity/ 
choice and control they have and more insight 
as to why SUs not compliant with taking 
medication.  
The course itself provided me with insight as to 
why patients were not compliant with 
medication, helping to develop strategies, our 
strategies with clients, it has helped basically to 
develop more skills in terms of medication 
insight, they don’t want to talk about 
medication all the time. 
 Service users need to have better 
understanding of their medication.  
There is more educative awareness for SU’s and 
also to provide them with a more structured 
approach, together with information presented 
on the course.  
My favourite approach was not methodical, not 
structured the way it should be done, but going 
to the course I have more insight, how to 
implement it, how to bring some changes, so 
definitely it has helped and the knowledge is 
worthwhile though this one is more methodical 
way of implementing it’s a successful way. 
 it’s very structured and there is rationale for 
doing that, I can implement it differently and 
the success rate is higher than the normal 
approach , I’m not saying it is a big high jump 
1. Have learnt that 
patients’ choices and 
feeling in control are 
important to MC. 
2. Have developed new 
ways of working with 
noncompliant patients and 
can help them to develop 
care plans other than just 
talking about medication. 
3. The patients should be 
educated more about their 
medication to improve 
compliance. 
4. The course has 
increased the 
competencies of the nurse 
in adopting a new 
structured approach to 
RPMC in practice 
5. Can now find that 
changing to the new 
approach has been 
successful in helping the 
nurse and in turn the 
patients, to improve on 
RPMC 
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 but at least slightly higher than normal approach 
as research involved. 
I am not saying that my attitude changed 
because we have to understand why the client 
doesn’t want to accept medication or do not 
want to take their medication.  
As key issue, I said to you my attitude has 
changed because obviously, you have to 
understand from their point of view, it gave me 
more empathy, in putting myself in their shoes 
and how to deal with it. 
I mean I can’t exactly say yes that you have to 
take this medications.  
If I was a clinician obviously it will have an 
impact but if you’re a manager it will have a 
very limited effect but the knowledge will help 
you to train your clinicians.  
So if you have a firsthand knowledge of relapse 
prevention this information can be shared with 
your practitioners, if I’m a manager I am not 
dealing with clients directly. 
Yes, very true and I have gained skills and 
knowledge. 
6. It could be only a slight 
improvement in MC but it 
is visible and encouraging 
from the nurse’s point of 
view 
7. It is simply a nursing 
duty that the nurse is 
talking about but changes 
in attitude have occurred 
since the course in that 
they are more empathetic 
and acknowledge the 
possibility that they do not 
understand the reason 
patients are not taking 
their medication. 
8. The course is helpful in 
sharing information even if 
you are a manager. 
9. Overall there seemed to 
be an improvement in 
skills and knowledge after 
the RPMC course. 
 
E21 
 
With my cultural background, I can explain to 
clients which is very important to take 
medications and explaining them about their 
medications. 
1. I can now work with 
clients to take their 
medication because of the 
learnt skills from the 
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I have learnt these skills from course.  
I have now changed my approach to more 
structured, methodical way and therefore 
implementing MC better now.  
course in linking culture 
and effects of taking 
medication. 
2. Now nurse seemed to 
believe a more structured 
approach in a systematic 
manner is useful in 
practice. 
 
E20 
 
One of the main ones is the culture of people 
like some of them who are Muslims they think if 
they read Quran it will help them to calm down 
their thoughts. With my cultural background, I can 
explain to clients it’s very important to take 
medications and explaining them about their 
medications. I have learnt more of these skills from 
course. 
I can recognise their cultural background and 
their beliefs. Now with the training done, it has 
enlightened my way of thinking and ways of 
relating to people about their religious and 
cultural backgrounds and what impact this can 
have on someone’s mental health and our 
interventions to improve their mental health. 
They have alternative therapies or treatment 
apart from the medical regime. 
1. Can now deal with 
cultural issues which may 
affect MC by explaining to 
them in a more 
appropriate way about 
their medication. 
2. Nurse is now able to 
think clearly about people 
with different religious and 
cultural backgrounds and 
can engage with them 
better in order to draw up 
an RPMC plan to improve 
their mental health. 
 
 
I have a greater understanding of EWS and 
increase negotiation skills to inspire confidence 
1. Have increased ability to 
assess EWS and confidence 
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 E22 
 
through motivating them to take their 
medication. 
I have also an increase in negotiation skills to 
increase service users’ confidence and to 
increase their motivation levels.  
I have increased ability to understand service 
users’ capacity, choice and control.  
in motivating patients to 
take their medication. 
2. Much improved skills to 
instil confidence and 
motivation in patients to 
take medication. 
3. Acknowledges what 
patients are able to do 
regarding making choices 
and taking control of self-
administering medication. 
Level 2 Summary Interpretation of Q3.1 
        Level 2: Summary Interpretation of Q3.1 by the Focus  Group 
The course has improved the capability of service users for better MC. More 
importantly, nurses have recognised the importance of developing an RPMC plan in a 
structured and systematic manner. Although it is too early to verify its success in 
practice, the nurses tentatively feel satisfied about the positive outcome of MC in 
practice. Two important concepts that nurses’ skills have improved are: assessing the 
perceptions and negative beliefs of service users about their medication, and sharing 
knowledge with patients to report their EWS to activate an RPMC plan quickly, to 
prevent a lapse or relapse episode. The participants’ attitudes seem to have changed 
by working with cultural and religious issues that may affect MC. The course has 
emphasised that building good relationships whilst showing empathy seems 
preferable to the traditional view of the patient being passive about their treatment. 
The belief is that helping the patients to be in charge of their treatment and making 
choices independently or in agreement with the nurses may be more productive in 
getting them to take their medication. 
Thematic Analysis of Interviews Transcripts 
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 Q4. Have you made any adaptations to your previous approach to medication 
concordance?  
Interviewees: All respondents except for E39 replied ‘yes’. 
Level 1 Interpretation 
They all think that something has changed in their practice but E39 has moved to a 
different job where he/she could not make changes to his/her practice. 
 
Q4.1: What adaptations have you made in the use of RPMC techniques in your practice 
setting? 
Q4.1  Reflective Quotes Level 1 Interpretation 
 
E9 
Developing strategies, it has provided me with 
broader knowledge. 
I have been implementing strategies with clients 
who don’t want to take their medication, 
making them aware of medication.  
 
1. The nurse’s enhanced 
knowledge has improved 
the RPMC Plan. 
2. Raising patients’ 
awareness of the cost 
benefits of the RPMC plan 
against not wanting to take 
medication. 
E39 NA  
 
E21 
 
 
I can understand service users’ concept towards 
medications, improvement to their mental 
state, medication and tend to trust their beliefs 
and it just helps my practice now as I have a 
better relationship with the family because now 
1. Meeting patients’ needs 
through negotiation, to 
understand their beliefs 
and to improve their 
mental wellbeing. This 
incorporates working with 
131 
  you are doing things the way they wanted or the 
way they would like to do things.  
We are able to have trust to improve way of life.  
the family and allowing 
them to make choices in 
negotiation with the nurse.  
 
 
E20 
 
 
 
Yes, I think so yeah, I think yes, more so in terms 
of a bit more reflective in terms of someone 
taking medication and the experiences they 
have and so many people don’t want to take 
medication, it’s not something they want to 
become dependent upon as people don’t feel 
themselves. It’s about advising people and 
making sure they have autonomy and as much 
choice as possible. 
1. Can now understand 
better that they do not 
want to take their 
medication because of 
negative side-effects. 
Despite that negative 
feeling, the nurse works 
with them to allow them 
more freedom of choice. 
 
 
 
E22 
 
Being more task-driven, focused on medication 
aspects.  
Provision of relevant information to enhance 
service users’ knowledge on an ongoing basis.  
Ongoing 1:1 discussions about negative and 
positive effects of medication and/or mixing 
with illegal substances and poor dietary intake.  
1. More practically 
orientated in adopting 
learning methods from the 
course to improve 
awareness of medication 
2. Provide them with 
information on a 1:1 basis. 
3. Discuss pertinent issues 
such as taking drugs whilst 
on medication or 
improving overall 
wellbeing. 
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 Level 2 Summary Interpretation of Q4.1 
        Level 2: Summary Interpretation of Q4.1 by the Focus Group 
Nurses are seemingly more capable of developing RPMC plans following the course. 
Their strategies include: information sharing, dealing with the negative side-effects of 
medication, issues with drugs whenever they arise and working with families. All 
these interventions are carried out in a user-friendly way, thus making patients’ 
choices easier and in this way the RPMC plan is more likely to succeed. 
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